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Abstract
This thesis investigates the role that the RNA binding protein Hfq has in
regulating the mobility of IS Elements and the expression of their transposase
genes. Hfq is a known regulator of the IS Element IS10 and is a major
component of sRNA pathways in E.coli. In this work, I demonstrate that through
the use of a bioinformatics approach to identify a list of additional IS Elements
from the IS Finder database, one can successfully identify IS Elements
containing Hfq binding sites which may implicate Hfq regulation. One of the
identified elements, IS1413, was characterized by transposition assays and
transposase expression assays. These experiments demonstrated that the
activity level of IS1413 decreases in the presence of Hfq. Another identified IS
Element, IS10, had its 3’ end of its transposase mRNA transcript probed for the
relevance of a putative Hfq binding site through mutational analysis, and through
identifying that there are no post-transcriptional modifications at the 3’ end of the
transcript. Although Hfq bound IS10 mRNA in vitro, genetic mutations to the
putative Hfq binding site resulted in no difference in transposition activity. A
growth condition was identified that increased IS10 transposition frequencies in
wild type cells, but not in cells containing a rpoS gene disruption. Overall, these
studies have identified another IS Element that changes activity in the presence
of Hfq and have linked slow unaerated growth conditions to an increase in IS10
transposition frequencies in E.coli.
Key words: IS10/Tn10, IS1413, Hfq, Stress Conditions, Transposition, E.coli,
Burkholderia phenoltripix, IS Finder
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Chapter 1 - Introduction
1.1 Lateral gene transfer in bacterial populations:
One of the driving forces of bacterial evolution is thought to be the ability to
exchange DNA between populations via lateral gene transfer (reviewed in 1).
Promiscuous DNA transfer can result in foreign genes being transferred from
species to species, potentially conferring new survival traits in the recipient
(including pathogenicity or antibiotic resistance) 1. By analyzing the genome of
E.coli MG1655 for DNA with different base compositions and different codon
bias, Lawrence et al. inferred that 17.6% of open reading frames of the genome
were acquired from at least 234 lateral gene transfer events 2. Mechanisms of
lateral gene transfer include transduction, conjugation and transformation (See
Figure 1.1). Transduction involves a bacteriophage incorporating some host
DNA into its capsid and upon infection, incorporating it into the recipient’s
genome. Transformation entails the uptake of DNA from the environment.
Conjugation refers to bacteria transferring self-mobilizing plasmids through sex
pili from one cell to another. Conjugation can occur between bacteria, bacteria
and plants 3, or bacteria and yeast 4, increasing the diversity of transmissible
genes. Transposons are often carriers of antibiotic resistance genes; their ability
to transpose onto phage or self-transmissible plasmids make them a major
component in lateral gene transfer 5.
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1.2 Transposons:

Many bacteria carry DNA transposons which are mobile genetic elements
that can move to various loci throughout the genome. Transposition events can
have consequences on the host such as gene deletions, inversions 6 and gene
activation 7.

Figure 1.1 Mechanisms of lateral gene transfer. Transduction involves a
bacteriophage injecting its genetic material into a recipient bacterial cell.
Transformation involves the cellular uptake of DNA from the environment.
Conjugation involves the active transfer of DNA from one cell to another through
a sex pilus.

2

There are three major classes of mobile genetic elements found in
bacteria: Insertion sequences (IS Elements), composite transposons, and
conjugative transposons (see Figure 1.2). IS Elements (top of Figure 1.2) are
comprised of genes necessary to facilitate their own mobility, such as a
transposase. Many IS Elements are flanked by inverted repeats which often act
as the boundaries of the IS Element and the transposase binding region. When
two IS Elements flank a common genomic region they can form a composite
transposon (bottom of Figure 1.2). The two IS Elements of the composite
transposon may or may not be completely identical; however, as long as one of
the IS Elements encodes a functional transposase, the entire composite
transposon can move as a single unit. Conjugative transposons are larger
mobile elements than IS Elements and composite transposons (middle of Figure
1.2). Conjugative transposons, such as Tn914, encode genes required for cellto-cell transfer, an integrase for integration into the chromosome, an excisionase
which excises the element from the host’s chromosome and often antibiotic
resistance genes such as tetracycline (reviewed in 8). The abundance of IS
Elements in a genome is exemplified with the 37 IS Elements present in E.coli
MG1655 2. Mobile genetic elements are also very prevalent in Burkholderia
cephacia, where the study of catabolite gene activation by IS Elements has been
extensively studied 9. Overall, the abundance of mobile genetic elements in
bacterial genomes may play a role in changing the overall architecture of the host
over time and may confer survival advantage to the host in times of
environmental stresses. The tetracycline carrying conjugative transposon
CTnDot is an example of a mobile genetic element playing a role in stress
3

adaptation. Upon exposure to tetracycline, the rates of CTnDOT excision from
the host chromosome increases 10.

Figure 1.2 The differences between insertion sequences, transposons and
composite transposons. Top: Insertion Sequences (IS Elements) are DNA
sequences that only encode genes involved in their mobilization (such as a
transposase). Many (but not all) IS Elements are flanked by inverted repeats
which act as the IS Elements’ boundary and often serve as the binding regions
for the transposase. Middle: Conjugative transposons are much larger than IS
Elements and contain gene clusters of similar function. Conjugation genes (light
blue) are involved in the transfer of the excised circular form of the transposon to
a recipient cell. Antibiotic resistance genes (R Gene) can also be carried within
the transposon (orange). Regulatory genes (brown) are often general
transcription factors involved in regulating the expression of the element’s own
genes. Excisionase (dark blue) is involved in excising the element from the
host’s chromosome to allow the element to circularize into its transmissible form.
The integrase genes are involved in integrating the element into the bacterial
chromosome. Bottom: A composite transposon is made when two IS Elements
mobilize to a genomic region within close proximity to one another. The region
that is trapped between the two IS Elements becomes part of the mobile element
when the transposase binds the outer boundaries of the composite transposon.
Often the genomic region between the two IS Elements is often an R Gene, or
another survival enhancing trait.
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1.3 Regulation of mobile elements:
Mobile genetic elements depend on the survival of the host to maintain
their existence. With host gene rearrangements and deletions being possible
consequences of transposition, mobile genetic elements are under tight
regulation by both the host and the mobile genetic elements themselves to
maintain the viability of both. Ultimately, the frequencies of transposition are
dependent on the amount of transposase (the enzyme responsible for element
mobilization) present in the cell 11. Down regulation of the transposase at the
expression level and transposon-binding level makes transposition events a rare
occurrence. For example, IS10 transposes at a rate of 10-4 events per cell
generation 12, and Tn10 has an even lower transposition rate of 10-7 events per
cell generation 13.
1.3.1 Regulation of transposase expression:
Transposons and IS Elements are often poorly expressed from moderate
endogenous promoters coupled with suboptimal ribosome binding sites

14

,

resulting in small amounts of transposase available in the cell to perform the
transposition reaction. Transcription levels of transposases can also be affected
by host factors. For example, DNA Adenine Methyltransferase (DAM) in E.coli
down regulates IS10 transposase expression at the transcriptional level through
the methylation of an adenine within the -10 region of the promoter, resulting in
reduced promoter activity 15. Anti-sense RNAs can also regulate transposon

5

expression, such as in IS10/Tn10, where an anti-sense RNA (RNA-OUT) base
pairs with the transposase mRNA (RNA-IN) resulting in the occlusion of the RBS.
1.3.2 Post translational regulation of transposons:
Host factors can also play a role on mobilization of transposons at a post
translational level. Host factors play an important role in the regulation of
transposition (reviewed in 16). Tn10 is both positively and negatively regulated by
host factors. DAM, in addition to regulating IS10 transcription, also methylates an
adenine found within the inside end of IS10 which reduces transposase binding
15

. Another host factor, Integration Host Factor, positively regulates Tn10

transposition through binding the transposon ends promoting the formation of the
paired ends complex (a step in IS10/Tn10 transposition) 17. The host factor Hfq
has also been implicated in IS10 regulation; E. coli strains with a hfq gene
disruptions (Hfq-) show a 50-86 fold increase in IS10 transposition when IS10 is
on a multi-copy plasmid, compared to cells with functional Hfq 18.
1.4 Hfq and sRNAs:
Hfq is an RNA binding protein that forms a homo-hexameric ring from 11.2
kDa monomers 19. It is a member of the SM/LSM family of proteins, containing
the SM1 motif found in Eukaryotic SM and LSM proteins

20

. In Eukaryotes, SM

and LSM proteins are involved in DNA and RNA processing events such as premRNA splicing and telomere synthesis 21. In bacteria, Hfq is a key component in
small RNA (sRNA) regulation in bacteria. One of the more defined roles of Hfq is
in promoting pairing of trans-encoded sRNAs with their targets. Recently, Hfq

6

has been shown to be involved in accelerating the rate of pairing a cis-encoded
sRNA (IS10’s RNA-OUT) to RNA-IN in vitro18. Both trans-encoded and cisencoded sRNAs are analogous to Eukaryotic micro RNAs (miRNAs) and small
interfering RNAs (siRNAs) in that they can alter the expression of their mRNA
targets through RNA destabilization or translation inhibition

22

.

Hfq can affect RNA molecules in at least 6 different ways (see Figure 1.3).
Firstly, Hfq can act in conjunction with an sRNA to block the ribosome binding
site (RBS) on its target mRNA which results in translation inhibition. In this case,
it is thought that Hfq acts to either promote pairing of the two RNA species
through binding and secondary structure alteration, or by physically increasing
the local concentrations of the two RNA species

23

(Figure 1.3A). RBS blocking

by an sRNA and Hfq is found in the regulation of fhl translation (an mRNA coding
for a transcriptional activator involved in the formate pathway in Enterobacteria)
by the sRNA OxyS; in this system, the OxyS binding site overlaps the RBS.
Upon binding to the fhl mRNA, OxyS directly competes with the 30S ribosomal
subunit for binding in an Hfq dependent manner 24. Secondly, Hfq and sRNAs
can actually increase translation initiation as well. An example of this is found in
the study of the DsrA:RpoS interaction. RpoS mRNA contains a secondary
structure in its 5’ UTR that results in the occlusion of the RBS. DsrA relieves this
secondary structure by pairing RpoS mRNA in an Hfq dependent manner making
the ribosome binding site accessible and allowing for ribosome binding 25 (Figure
1.3C). Thirdly, Hfq can also directly target the RBS of mRNA independent of an

7

sRNA, which in turn has a destabilizing effect on the half-life of the mRNA and
reduced translation (Figure 1.3B).
RNA stability which is affected by the frequency of translation initiation on
an mRNA by the 16S ribosomal subunit, and the initiator tRNA

26

. A reduced

frequency of translation initiation results in reduced mRNA levels in the cell

26

.

This is exemplified in the mRNA ompA, a message for an outer membrane
protein, where Vytvytska et al show Hfq can bind to ompA mRNA, preventing the
initiator complex from forming and ultimately making the mRNA vulnerable to
RNase E mediated degradation 27. Hfq is not just a promoter of RNA
degradation; in a fourth mechanism Hfq can also protect sRNAs from RNases by
blocking cleavage sites (Figure 1.3 F). For example, the sRNAs DsrA and RhyB
are protected from RNase E cleavage when Hfq binds and protects the RNase E
cleavage site on the sRNAs 28. In the fifth mechanism of how Hfq can affect
RNA, Hfq facilitated pairings of sRNAs can result in the degradation of both the
sRNA and target mRNA (Figure 1.3D). A study by Massé et al demonstrates
that in the Hfq facilitated binding of the sRNA RhyB to the mRNA sodB, both RNA
species are degraded in an RNase E dependent manner

29

. A sixth proposed

mechanism of Hfq is its involvement in the polyadenylation of mRNA transcripts
(Figure 1.3E). In a study by Mohanty et al, total cellular RNA from log phase E.
coli was analyzed for polyAdenylated (polyA) tail length; Hfq disruptions resulted
in a decrease in polyA tail length of greater than 20 nucleotides

30

. A

consequence of polyadenylation of mRNA in E.coli is the decrease of mRNA
stability 31.

8

Figure 1.3 Hfq modes of action. A) Hfq and an sRNA can bind the ribosome
binding site (RBS) of a target mRNA and inhibit translation. B) Hfq can directly
bind the ribosome binding site of an mRNA preventing the 30S ribosomal subunit
from binding. C) Hfq and an sRNA can positively regulate translation by altering
the secondary structure of an mRNA that is self-occluding the RBS. D) RNase E
can associate with Hfq’s C-terminus and degrade mRNA that the Hfq:sRNA
binary complex is base paired with. E) Hfq can recruit poly(A) polymerase to the
3’ end of an mRNA, resulting in polyadenylation and subsequent destabilization
of the transcript. F) Hfq can directly bind sRNAs and protect them from
degradation
The impact of Hfq and sRNAs on gene regulation in bacteria is becoming
apparent. To date, there are numerous classes of regulatory RNAs, including:
cis-encoded RNAs encoded on the opposite stand of the mRNA, trans-encoded
sRNAs which are often found in intergenic regions of the genome , and Clustered
Regularly Interspaced Short Palindromic Repeats (CRISPR) RNAs (reviewed in
22

). These 3 subclasses of small RNAs are transcribed from different parts of a

bacterial genome and have different mechanisms of action. Cis-encoded RNAs

9

are encoded from the opposite DNA strand that codes for the mRNA, so they
have perfect complementarity to a region of their target mRNA (reviewed in 32).
Trans-encoded sRNAs are often encoded in intergenic regions of the genome
and can have multiple targets with limited complementarity; many trans-encoded
sRNAs are dependent on Hfq to effectively basepair with their target mRNA
(reviewed in 22). CRISPR RNAs are found clustered in 1 or 2 loci of a bacterial
genome and are thought to protect the cell from phage infection; research into
the mechanism of action these CRISPR RNAs is still in preliminary stages
(reviewed in 33).

The first cis-encoded sRNA reported to regulate a transposon was the
RNA-OUT transcript of Tn10 34. RNA-OUT is an anti-sense RNA that base pairs
with RNA-IN (the transposase mRNA) ultimately resulting in the occlusion of the
ribosome binding site and start codon, leading to reduced transposase
expression 34. Hfq may be involved in pairing of IS10’s RNA-IN and RNA-OUT 18
by increasing the half-life of RNA-OUT, by altering the secondary structure of the
two RNA species making pairing more favourable or by increasing the local
concentrations of the two RNA species making binding more probable. Other
examples of cis-encoded RNA control have since been identified and
characterized. An interesting study that found a connection between cis and
trans-encoded sRNAs was on the luxS mRNA and its interaction with the sRNA
MicA. MicA interacts with OmpA as a trans-sRNA; MicA is also a cis-encoded
sRNA that, upon pairing with its target mRNA luxS, results in a processed
transcript 35. This interaction suggests that cis-encoded sRNAs may act on more

10

targets than their perfectly complementary partner mRNA and thus could be
regulating a multitude of mRNAs by acting as a trans-sRNA as well. Generally,
Hfq is not thought to be required for cis-encoded RNAs to pair with their target
mRNA. However, Hfq’s role in sRNA stability suggests that Hfq may be required
for these sRNAs to have sufficient stabilities in vivo to act on their targets.

Trans-encoded sRNAs in E.coli are encoded from regions distant from their
numerous targets. Trans-encoded sRNAs are frequently expressed in response
to stress stimuli to the cell which can include oxidative stress (which induces the
sRNA OxyS) 36 or low temperature growth (which induces the sRNA MicC) 37.
Trans-encoded sRNAs often require the RNA binding protein Hfq to promote
pairing to their mRNA targets 38. A well characterized sRNA:mRNA pairing
reaction is between the sRNA GlmZ and the glmS mRNA (which encodes an
enzyme involved in glucosamine-6-phosphate synthesis) 39. Without the
activating sRNA glmZ, the 5’ untranslated region of the glmS RNA forms a hairpin
occluding the ribosome binding site; Hfq binds to both GlmZ and glmS RNA
species. GlmZ binds to glmS mRNA upstream of the Shine-Dalgarno in an Hfq
dependent manner, resulting in an secondary structure change of the mRNA and
an available ribosome binding site

39

. Overall, sRNAs allow the cell to quickly

respond to cellular stresses through a network of sRNAs without the need to
invest energy in regulatory proteins. Given that there is still a 7-fold increase in
transposition in the absence of Hfq and the anti-sense RNA-OUT, there may be
yet another undiscovered RNA-Hfq interaction involved in down regulating IS10
transposition such as an endogenous sRNA interacting with RNA-IN.

11

The Hfq hexamer has two distinct RNA binding surfaces, known as the
40

proximal and distal faces (reviewed in

). The two different faces of the Hfq

hexamer are thought to bind different RNA sequences with the proximal face
binding polyA/U sequences and the distal face binding sequences rich in the
sequence ARNx (where R is a purine and N represents any nucleotide) 41. Hfq is
also able to bind DNA in a sequence independent manner

42

. Physiological

concentrations of Hfq favour hexameric and multimeric forms of Hfq; the
hexameric form is the active RNA and DNA binding form of the protein43. A study
utilizing Genomic systematic evolution of ligands by exponential
enrichment (SELEX) identified additional sequences that Hfq bound with high
affinity: AAYAAYAA and AYAAUAA

44

.

1.5 Regulation of Hfq expression:
Transcription of hfq is driven from 3 promoters (two σ70-dependent and
one σ 35-dependent) from the hfq operon 45. Hfq self-regulates the amount of hfq
transcripts in the cell though the binding and destabilization of its mRNA in
exponentially growing cells 46. Hfq also self regulates its own translation by
binding to its own mRNA 47. Regardless of such regulation, Hfq remains
abundant in the exponentially growing cell with estimates ranging from 2500
molecules of monomer per cell 48 to 55,000 molecules of monomer per cell 49.
Deletions and disruptions of hfq result in shorter half-lives of small RNAs (sRNA)
28

, pleiotropic responses to cellular stress 50, and increased transposition of

Tn10/IS10. Tn5 transposition frequencies also increase in cells lacking functional
Hfq 51.
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1.6 Cellular factors that affect Hfq levels:
Recent studies by Hussein et al. and Moon et al. have shown that
overexpression of sRNAs can result in a titration effect on cellular Hfq
concentration. Most cellular Hfq is already bound to nucleic acids with 80-90% of
cellular Hfq associated with ribosomes and 10-20% being found in the nucleoid
52

. Further depleting the pool of free cellular Hfq may result in the expression of

genes that are normally repressed by Hfq thus allowing the cell to mount a quick
response to cellular stress 53,54. DksA is a transcription factor that responds to
amino acid starvation conditions in conjunction with ppGpp, which modulates
RNA polymerase activity; dksA deletion strains in E.coli and Shigella flexneri
reduce Hfq protein levels by 50% 54,55. Another cellular stress that results in
reduced Hfq levels, is the transition between exponential phase to stationary
phase which results in a 33% reduction of Hfq protein levels
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49

.

Figure 1.4 Features of IS1413: IS1413 contains two flanking inverted repeats (denoted IR Left and IR Right)
denoting the boundaries of the element. The +1* represents the transcriptional start based on 5’ RACE data (lab
data). The predicted start codon is found at bp 120. The … represents a break in the sequence. The stop codon
is denoted in red at bp 1391. A predicted Hfq binding site is bolded and denoted HBS using the predicted Hfq
binding aptamer (AAYAAYAA) 44. The IR Right portion of IS1413 contains a sequence TTGACG denoted -35*
which can act as the -35 portion of an E.coli promoter when inserting in front of another gene.
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1.7 IS1413:
IS1413 is an IS Element (Figure 1.) originally identified in Burkholderia
cephacia AC1100 (now known as Burkholderia phenoliruptrix) which was found
to occasionally create a promoter fusion with a promoterless streptomycin gene
56

. The promoter fusion occurs by the -35 sequence found in the right IR

sequence (Figure 1., shadowed text) inserting in front of a gene with a sequence
resembling the -10 region of a promoter. There are 10 to 12 copies of IS1413 in
the genome 56 and very little is known about the mechanism of transposition or its
regulation. IS1413 was discovered by its 83% similarity to IS1490 (the IS
element thought to be responsible for Burkholderia phenoltripix’s ability to break
down DDT) 56. IS1413 contains a perfect match for a potential Hfq binding site
(HBS) within its 5’ untranslated region (UTR) (Figure 1.). This Hfq binding site
may be indicative of a regulatory mechanism of IS1413 that involves Hfq.
1.8 Tn10:
Tn10 is a well-studied transposon that confers tetracycline resistance to its
host. Tn10 is a composite transposon comprised of two IS10 copies (IS10L and
IS10R) flanking tetracycline resistance genes (Figure 1.). IS10R is a functional
IS element that can mobilize either as an IS element when the transposase acts
at its inside and outside ends (Figure 1.), or mobilize the entire Tn10 element
when the transposase acts at the two outside ends. IS10L is a degenerate copy
of IS10 and does not encode a functional transposase

57

. The expression of

IS10’s transposase is under tight regulation from host factors and an antisense
RNA system. The antisense RNA system is self-encoded in the IS10R
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transposase gene which encodes two RNA species (Figure 1.); RNA-IN (the
mRNA of the IS10 transposase) and RNA-OUT (an anti-sense RNA that contains
35 bases that are complementary to the 5’ region of RNA-IN)34. Pairing of RNAIN and RNA-OUT results in the occlusion of the ribosome binding site of RNA-IN
58

and an RNase II dependent decrease in the half-life of RNA-IN 59. The anti-

sense control is of particular importance when multiple copies of IS10 are
expressed. When expressing IS10 on a multi-copy plasmid, the transposition
frequency of a single chromosomal copy of Tn10 decreases by about 20 fold 34.
This effect is known as multi-copy inhibition (mci). The mci effect can be
explained by the transposase encoded by RNA-IN being most effective when
acting on sequences close to where it was synthesized
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, in contrast to RNA-

OUT which can freely distribute through the cell. Furthermore, RNA-IN levels are
less than 1% that of RNA-OUT 11. The differences in RNA-IN and RNA-OUT
levels are due to RNA-OUT having a stronger promoter than RNA-IN and RNAOUT having a longer half-life than RNA-IN (70 minutes versus 40 seconds,
respectively) 11.
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Figure 1.5 Structure of Tn10 and key sequences of IS10R. O.E and I.E are
the outside ends and inside ends respectively. The IS10R encoded transposase
binds to the I.E and O.E. RNA-IN (the transposase mRNA) starts at the G
denoted in purple. The ribosome binding site (RBS) of RNA-IN is denoted in blue
and the translational start denoted in green. Downstream towards the 3’ region
of RNA-IN is a predicted Hfq binding site (HBS). The translational stop codon is
denoted in red within the I.E. RNA-OUT is the antisense RNA and is denoted in
the shadowed text. RNA-OUT is transcribed from the opposite DNA strand of
RNA-IN.
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1.9 Thesis topics addressed:
Transposons are heavily regulated by host factors. Hfq is a host factor
that negatively regulates IS10/Tn10 and IS50/Tn5. Hfq may be a global regulator
of many IS Elements. An RNA interference mechanism has already been
characterized in Eukaryotes that repress mobile genetic elements such as
viruses and transposable elements. Small interfering RNAs (siRNAs) and
microRNAs (miRNAs) are two defense mechanisms eukaryotes use to silence
genes (including transposons and viral genes); siRNAs result in the cleavage of a
target mRNA and miRNAs result in repressed translation or sometimes cleavage
of the target mRNA (reviewed in 60,61). Perhaps sRNAs could be functioning as a
Prokaryotic method of silencing transposable elements. Tn10/IS10 and Tn5/IS50
have already been shown to be repressed by Hfq which is closely connected to
the sRNA regulation in Bacteria. In this thesis I follow up on three main
questions:

1) Can transposons that are subject to Hfq dependent regulation be identified
by searching for putative Hfq binding sites in the transposase transcript?
2) Is an endogenous E.coli sRNA involved in Hfq-mediated regulation of
Tn10/IS10 transposition?
3) Does limiting the amount of synthesis or availability of Hfq influence
Tn10/IS10 transposition?

In this work I explored the effects Hfq has on the regulation of the two IS
Elements IS10 and IS1413 which were identified by searching for putative Hfq
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binding sites in the IS Finder database. IS10 contains an Hfq binding site in its 3’
region, however disrupting this Hfq binding site through mutation does not result
in a de-repression of Hfq in a transposition assay. IS1413 has an Hfq binding
site found within its 5’ untranslated region and for the first time I show it can
undergo transposition in E.coli at an average frequency of 3.7 x 10-5 ± 7.8 x 10-5
in the presence of Hfq and increases its average transposition frequency to 5.0 x
10-4 ± 3.8 x 10-4 in the absence of Hfq. I also identified that IS10 transposition
increases in wildtype cells by 9.81 ±1.64 fold when cells are starved and put
under non-aerating conditions. Finally I analyzed the 3’ region of IS10 to
determine where the transcript terminates and looked for a potential mechanism
in which Hfq could be acting on the RNA (such as facilitating polyadenylation). A
defined stop point which appears to either be due to a processing event or run off
transcription was found using the 3’ RACE technique.
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Chapter 2 - Materials and Methods
2.1 Bacterial strains used in this thesis:
All bacterial strains (E.coli and Burkholderia) used in this thesis are
compiled in Table 2.1. All plasmids used in this study are compiled in Table 2.2.
Bacterial strains with gene disruptions were made via generalized transduction.
Phage P1 was used for generalized transduction

62

. P1 Phage was used to infect

E. coli cells containing a “marked” gene of interest (containing an antibiotic
resistance gene). A culture of E.coli containing the “marked” gene was grown
overnight in LB broth with selection and subcultured in the absence of antibiotic
but supplemented with 25 mM MgCl2, 5 mM CaCl2, and 0.2% glucose to grow to
early log phase. Forty μL of P1 phage were added to the subculture of cells, and
further incubated for 3 hours at 37°C with aeration. Fifty μL of chloroform was
added to the infected cells, vortexed, and centrifuged at 6000 rcm for 5 minutes.
The supernatant was removed and stored at 4°C. Phage lysate was titred to a
multiplicity of infection of 1-5 plaque forming units/cell. NK5830 F’ cells
transformed with a temperature sensitive plasmid encoding recA (pET001) were
grown in LB broth overnight at 30°C with aeration. Cells were subcultured (1:20)
in LB broth containing 25 mM MgCl2, 5 mM CaCl2, and 0.2% glucose at 30°C with
aeration and grown to exponential phase. Cells and phage lysate were mixed at
a 1:1 ratio (100 μL of exponentially growing cells (undiluted, diluted by a factor of
10, or diluted by a factor of 100) and 100 μL of phage lysate) and incubated at
30°C for 60 minutes. Two-hundred microlitres of 1 M sodium citrate (pH 5.5) was
added to the transduction mix, followed by 1 mL of LB broth. Cells were
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incubated at 37°C with aeration for 60 minutes, spun down at 6000 rcm for 5
minutes and resuspended in 0.85% NaCl in H2O. Cells were plated on LB agar
containing 20 μg/mL of chloramphenicol and incubated at 37°C. Individual cells
picked from overnight plates and were serially passaged on LB agar containing
either 20 μg/mL of chloramphenicol as well as LB agar plates containing 100
μg/mL of ampicillin (to ensure the recA plasmid was lost) until colonies were
cured of the recA containing plasmid pET001.
Table 2.1 Bacterial strains used in this thesis
Strain

Description

NK5830 F'

recA56 su° lacproXII1, Arg-, Ara-, NalR,
RifR/F’ laciq L8 pro
NK5830F' transduced to hfq-1::Cm
NK5830F' Transduced to rpoS::cat (phage
from NM22542 ΔnlpD-rpoS CmR)
Burkholderia phenoliruptix AC1100 (Gift
from Dr. Zlosnik )
NK5830 ΔdksA::Tet (using phage lysate
from MG1655 ΔdksA::Tet from M.Cashel via
S Gottesman (CF9239)
NK5830Δ SroG::IS50-Kan-LacZ
F-, leu- ; StrR

DBH16
DBH48
DBH144
DBH174

DBH 181
HB101

Source/
Reference
63
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(Laboratory
stock)
A Gift from Dr.
Zlosnik (UBC)
This Study

Laboratory stock
64

2.2 Plasmids used in this thesis:
All plasmids used in this thesis are compiled in Table 2.2. Plasmids
pDH694-696 are pACYC184 derivatives; they contain pLlacO1 inducible sRNAs
(DsrA. MicC, and RhyB respectively).

These sRNA inducible plasmids were

constructed by PCR amplifying DsrA, MicC or RhyB from a genomic preparation
of NK5830 DNA using primer pairs BM43A and BM44A for DsrA, BM41A and
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BM42A for MicC and BM40A and BM39A for RhyB. PCR products were digested
using Nco I and Xmn I and cloned into Nco I/Xmn I digested pACYC184 plasmid.
For DsrA, MicC and DsrA PCR reactions the reaction conditions were as follows:
Genomic DNA preparations of NK5830 were done using the GenElute™
Bacterial Genomic DNA Kit (Sigma) following the manufacterer’s protocol. PCR
reactions were the same for all three pLlacO1 inducible sRNAs.

Reactions

consisted of 10 ng of NK5830F’ gDNA,, the sRNA respective forward and reverse
primers [1 μM each], combined with GoTaq Mastermix (Promega) [1x]. PCR
conditions were: 98°C (2 min) for the initial denaturation, followed by 98°C (30s),
65°C (40s), and 72°C (1 min) repeated 30 times. A final extension step was done
at 72°C for 5 min. The resulting amplicon was gel purified using the QIAEX II Gel
Extraction Kit (Qiagen).
The new IS10-Kan construct pDH725 and the BM1 mutant pDH734 were
generated by PCR amplifying IS10 on pDH669 (for WT) or pDH703 (for BM1
Mutant) from bp1 to the end of the stop codon at bp1316 using primers BM27A
and BM26A. Reactions consisted of 10 ng of template (pDH669 or pDH703),
forward and reverse primers [1 μM each], combined with GoTaq Mastermix
(Promega) [1x]. PCR conditions were: 98°C (2 min) for the initial denaturation,
followed by 98°C (30s), 62.2°C (45s), and 72°C (2 min) repeated 35 times. A
final extension step was done at 72°C for 5 min. The resulting amplicon was gel
purified using the QIAEX II Gel Extraction Kit (Qiagen). This IS10 amplicon was
cloned into pGEM-T-Easy (Promega). The kanamycin gene containing IS10’s
inside end was PCR amplified from pDH502 using the primers BM23A and
BM22A. The BM22A primer contains 27 bases of IS10’s inside end (IS10 I.E), 5’
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to the complementary sequence of the kanamycin gene.

PCR reactions

consisted of 10 ng of template (pDH502), forward and reverse primers [1 μM
each], combined with GoTaq Mastermix (Promega) [1x]. PCR conditions were:
98°C (2 min) for the initial denaturation, followed by 98°C (30s), 55°C (45s), and
72°C (2 min) repeated 5 times. Another set of PCR parameters of 98°C (30s),
68°C (45s), and 72°C (2 min) was then followed for 30 cycles: A final extension
step was done at 72°C for 5 min. The resulting amplicon was gel purified using
the QIAEX II Gel Extraction Kit (Qiagen).This kanamycin-IS10 I.E amplicon was
digested with Spe I and Xba I and cloned into the IS10-containing pGEM -T-easy
construct digested with Spe I.
The LacZ translational fusion plasmids pDH703 and 704 were made
through site directed mutagenesis of pDH669. For pDH703 primers BM10A and
BM11A were used with pDH669 and Pfu polymerase (Stratagene) according to
manufacturer’s guidelines for site-directed mutagenesis. For pDH704 primers
BM12A and BM13A were used with pDH669 and Pfu polymerase (Stratagene)
according to manufacturer’s guidelines for site-directed mutagenesis
The pDH734 (IS10-Kan BM1 mutation) was constructed by PCR
amplifying the IS10 fragment on pDH703 with primers BM26A and BM18A. PCR
reactions consisted of 10 ng of template (pDH703), forward and reverse primers
[1 μM each], combined with GoTaq Mastermix (Promega) [1x]. PCR conditions
were: 98°C (2 min) for the initial denaturation, followed by 98°C (30s), 62.2°C
(45s), and 72°C (2 min) repeated 25 times. A final extension step was done at
72°C for 5 min. The resulting amplicon was cloned into pGEM T-easy vector
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(Promega). The construct was digested with SpeI and the gel purified using the
QIAEX II Gel Extraction Kit (Qiagen).
The IS1413 containing plasmid pDH735 was constructed by PCR
amplifying IS1413 from a genomic DNA preparation from Burkholderia
phenoltripix AC1100 using primers BM1A and BM2A.

The Taq polymerase

amplified amplicon was cloned into pGEM T-easy (Promega).

The mutated

IS1413 LacZ translational fusion plasmids pDH760 and pDH794 were both made
by amplifying the IS1413 portion of pDH757. The forward primers BM4A and
BM3A contain a Nhe I cut site as well as the IS1413 SELEX mutations C and B
respectively (see Figure 3.1B). The reverse primer used to amplify IS1413 for
LacZ translational fusions was BM5A which contains a Sph I cut site. Amplicons
of IS1413 mutants B and C were digested with Nhe I and Sph I and cloned into a
Nhe I/Sph I digested pBad 24 vector. The kanamycin ‘marked’ IS1413 construct
pDH797, was made by first doing site-directed mutagenesis on IS1413 using
primers BM1A and BM7A with pDH735 as a template to introduce a Xho I cut site
after the stop codon in the IS1413 transposase gene. The resulting amplicon
contained a truncated IS1413 (missing 27 nucleotides), to rectify this, the Xho I
containing amplicon was used as a template for another PCR reaction using
BM1A and BM6A primers.

The resulting amplicon was a full length IS1413

sequence containing a Xho I cut site and was cloned into pGEM-T Easy
(Promega) to make pDH796.
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Table 2.2 Plasmids used in this thesis.
Plasmid

Description

Source or
Reference

pDH502
pDH602
pDH662

pBR322-hISG1::IS10KAn (pNK1219)
pACYC184- HisG1::IS10Kan
1-121 IS10 translational fusion to the 9th codon of LacZ
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pDH663

1-180 IS10 translational fusion to the 9th codon of LacZ

pDH664

1-290 IS10 translational fusion to the 9th codon of LacZ

pDH668

1-1020 IS10 translational fusion to the 9th codon of LacZ

pDH669

1-1320 IS10 translational fusion to the 9th codon of LacZ

pDH676
pDH694

Tn10 in a broad host range plasmid (pBE10)
pACYC184 encoding pLlacO-1 promoter driving expression of DsrA (as a pcr fragment
cloned into Nco I/Xmn I-cut pACYC184)
Same as 694 but with MicC
Same as 695 but with RyhB
pDH669 containing the BM1 mutation
pDH669 containing the BM2 mutation
Kanamycin marked IS10 with no repeated sequence
pDH725 with a mutated putative Hfq binding site Tyr 374 TACTAT (found just outside
of the SELEX site) and an Arg 378 AGG CGG
IS1413 in pGEM T-easy
IS1413 (up to bp 445) lacking -10/-35 ligated into MCS of pBAD24 ampR

pDH695
pDH696
pDH703
pDH704
pDH725
pDH734
pDH735
pDH757
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Unpublished, a
gift from C. Jain
Unpublished, a
gift from C. Jain
Unpublished, a
gift from C. Jain
Unpublished, a
gift from C. Jain
Unpublished, a
gift from C. Jain
66

This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
Morgan Black’s
Fourth Year
Thesis

pDH760
pDH794
pDH796
pDH797
pDH763
pDH783
pET001

IS1413-LacZ (from 757) lacking native promoter sequence with a mutated Hfq binding
site (GAACACCAA) cloned into MCS (NheI/SphI) of pBAD24
Same as pDH760 only SELEX mutation = TAAACTACAA
1413 in pGEM mutations at A1397C,T1402G to make a XhoI cut
Sph I-Kan-Sph I PCR product (from 602) cloned into pDH796 Xho I site
Empty pLlacO1 vector (pBR322 derivative
plLac-GlmZ (pBR322 derivative)
pRR10-ts97-derived recA; temperature-sensitive plasmid; AmpR
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This Study
This Study
This Study
This Study
67
67
68

A kanamycin resistance gene was amplified from pDH502 using primers
BM24A and BM25A. The resulting amplicon was digested with Sph I and cloned
into the Xba I site of pDH796 to make pDH797.
2.3 Mating out assay:
For the mating out assays, NK5830 F’ and its isogenic mutant, Hfq-, RpoS-,
H-NS-, or DksA-, derivatives were used as donors and HB101 as the recipient.
IS10/IS1413-Kan encoding plasmids (pDH502, pDH602, pDH725, pDH734, or
pDH797) were transformed into donor strains through electroporation and
transformants were selected for on LB plates containing kanamycin [25 μg/mL].
Under normal circumstances (Normal Mating Out), overnight cultures of donor
cells were grown overnight at 37°C with aeration to saturation in LB broth
containing kanamycin [25 μg/mL]. Overnight cultures were subcultured in LB
broth in the absence of antibiotics. For the mating out assay under starvation
conditions (Starved), donor cells were grown at room temperature (~25°C) on
benchtop (no aeration) in LB containing kanamycin [25 μg/mL] for 110 hours then
subcultured in LB broth in the absence of antibiotics.

The first step of

subculturing consisted of diluting overnight cultures (1:20) in LB broth and
growing for 2 hours with aeration (250 rpm) for Hfq+ and RpoS-). For Hfq- and
DksA-(cells), the first step consisted of diluting overnight cultures (1:20) in LB
broth and growing for 4 hours with aeration (250 rpm). After the first step of
subculturing, Hfq+ and RpoS- cell cultures were moved to a gentle shaker (50
rpm) at 37°C for an additional 2 hours. Cell cultures containing Hfq- and DksAdonor cells were grown with gentle shaking for 50 rpm for 4 additional hours. The
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extended growth time for the mutant strains allowed the slow growing Hfq- and
DksA- donor cells to reach a similar cell density as the NK5830F’ cells. Recipient
HB101 cells were grown in LB broth at 250 rpm at 37°C to reach an OD600 of 0.5.
Recipient and donor cells were gently mixed at a ratio of (2.5 mL : 1 mL)
respectively and grown at 50 rpm at 37°C for an additional hour. Cell mixtures
were vortexed for 30 seconds. One mL of cell mixture was removed, centrifuged
(4000 rcm for 4 minutes) and resuspended in 1 mL of 0.85% saline.

To

determine the number of exconjugates (recipient cells that received the Fplasmid), cell mixtures were plated on M9 plates containing glucose [0.2%],
leucine [40 μg/mL], thiamine [1 μg/mL] and streptomycin [150 μg/mL].

To

determine the number of transposition events (cells that received an F-plasmid
that also contained a marked IS element), cell mixtures were plated on M9 plates
containing glucose [0.2%], leucine [40 μg/mL], thiamine [1μg/mL] streptomycin
[150 μg/mL], and kanamycin [25 μg/mL].

The transposition frequency was

determined by the following equation:

For the sRNA overexpression mating out assays, the same procedure
outlined above was followed with the following exceptions. NK5830 F’ and its
Hfq- isogenic mutant DBH16 were co-transformed with pDH502 as an IS10-Kan
source and one of the sRNA expression plasmids (pDH694-696) for DsrA, RhyB
or MicC.

Transformants were plated on LB-selective media containing

tetracycline [10 μg/mL] and kanamycin [25 μg/mL] either in the presence or
absence of 1mM IPTG for induction.
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Selection and induction conditions

remained the same for overnight cultures. The rest of the procedure remained
the same as outlined above. For GlmZ overexpression, the same procedure was
followed with the exceptions outlined below.

The source of IS10Kan was

pDH602 (to avoid plasmid incompatibilities). IPTG was used at a concentration
of 100 μM and the antibiotics used were ampicillin [50 μg/mL] and kanamycin [25
μg/mL]. Cells were checked after the overnight incubation (by using the SigmaAldrich Mini-prep kit) to ensure cells maintained both plasmids.

Table 2.3 Oligos used in this thesis.
Oligo
BM1A

Use
Forward primer for IS1413

BM2A

Reverse primer for IS1413 (Full Length)

BM3A

Forward primer for IS1413 SELEX site
mutation B in the LacZ translational
fusion)
Forward primer for IS1413 for mutation
C in the SELEX Site for LacZTranslational fusions
Reverse primer for LacZ gene for
introduction into pBad24 vector
Reverse primer to complete the IS1413
sequence in the Xho I mutation
Reverse primer for introduction of a Xho
I site into IS1413
Forward primer #1 for IS10 3’ RLMRACE nested PCR
Forward primer #2 for IS10 3’ RLMRACE nested PCR
Forward primer for introduction of the
BM1 mutation in IS10

BM4A

BM5A
BM6A
BM7A
BM8A
BM9A
BM10A

BM11A

Reverse primer for introduction of the
BM1 mutation in IS10
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Sequence
GAGCTAAAGTCGGAAGT
GGTGTACGGGGAGTTGA
GGC
GAGCTAACGTCAAGAGTG
GTGTATGAGCAATTTGA
CGTAGCTAGCAGCTGATT
GTCGAAGTCGGAAGCCA
GCGAACACCAA
CGTAGCTAGCAGCTGATT
GTCGAAGTCGGAAGCCA
GTAAACTACAA
CGATGCATGCACTGTTAT
TTTTGACACCAGACC
TCAAATTGCTCATACACC
ACTCTTGACGTTAGCTC
AGCAATTTGACGGCGCTC
GAGTTCAAGC
GAGCCATGGGTTCTAGCA
ACTAACTTACC
TACGCCATAGCCGAACGA
GCAGC
TTGCGGCATTCTGGCTAT
ACAATAACACGGGAAGAC
TTACTCG
CGAGTAAGTCTTCCCGTG
TTATTGTATAGCCAGAAT
GCCGCAA

BM12A

Forward primer for introduction of the
BM2 mutation in IS10

BM13A

Reverse primer for introduction of the
BM2 mutation in IS10

BM14A

Forward primer for 3’ RNA-IN (includes
a T7 RNA Polymerase promoter)

BM15A

Reverse primer for 3’ RNA-IN (includes
a T7 RNA Polymerase promoter)
Forward primer for 3’ RNA-IN BM1
(includes a T7 RNA Polymerase
promoter)
Reverse primer for 3’ RNA-IN BM1
(includes a T7 RNA Polymerase
promoter)
Reverse primer to introduce a stop
codon in the IS10-LacZ translational
fusions, for subsequent cloning to
make the new IS10-Kan construct
Reverse primer (1) for the RNA-Adapter
in 3’ RLM RACE nested pcr
(DE-193)
Reverse primer (2) for the RNA Adapter
in 3’ RLM RACE nested PCR
RNA Adapter
(DE-194)
RNA-Adaptor for 3’ RACE

BM16A

BM17A

BM18A

BM19A

BM20A

BM21A

BM22A

Forward primer for kanamycin
resistance gene

BM23A

Reverse primer for kanamycin
resistance gene

BM24A

Forward primer for kanamycin gene
(with a Sal I cut site introduced)
Reverse primer for kanamycin gene
(with a Sal I cut site introduced)

BM25A

BM26A

Forward primer for IS10

BM27A

Reverse primer for IS10

30

TTGCGGCATTCTGGCTAC
ACGATAACGAGGGAAGA
CTTACT
AGTAAGTCTTCCCTCGTT
ATCGTGTAGCCAGAATGC
CGCAA
TAATACGACTCACTATAG
GGCTGGCTACACAATAAC
AAGGGAAG
CTGAGAGATCCCCTCATA
ATTTCCCCA
TAATACGACTCACTATAG
GGCTGGCTATACAATAAC
ACGGGAAG
TAATACGACTCACTATAG
GGCTGGCTACACGATAAC
GAGGGAAG
TCATAATTTCCCCAAAGC
GTAACC

TTTCATCAAAGCCAGCAA
ACGC
CAAACGCAGTGTTCATTC
ATCGCC

GCUGAUGGCGAUGAAUG
AACACUGCGUUUGCUGG
CUUUGAUGAAA
GCTCTAGACTGAGAGATC
CCTCATAATTTCCCCTCA
GCAAAAGTACGATTTATT
CAAC
GGACTAGTGCCAGTGTTA
CAACCAATTAACCAATTC
TGA
ACGCGTCGACTCAGCAAA
AGTACGATTTATTCAAC
ACGCGTCGACGCCAGTG
TTACAACCAATTAACCAAT
TCTGA
NNCAGCTGATGAATCCCC
TAATGATTTTGG
GGACTAGTTCATAATTTC

BM28A
BM29A
BM30A
BM31A
BM32A

Forward primer for rrsb (16S rRNA) RTPCR
Reverse primer for rrsb (16S rRNA) RTPCR
Forward primer for glmZ RT-PCR
Forward primer for glmZ (includes a T7
RNA Polymerase promoter)
Reverse primer for glmZ

BM33A

Forward primer for rdlC (includes a T7
RNA Polymerase promoter)

BM34A

Reverse primer for rdlC

BM35A
BM36A

Forward primer for sroG (includes a T7
RNA Polymerase promoter)
Reverse primer for sroG

BM37A

Forward primer for micC RT-PCR

BM38A

Reverse primer for micC-RT-PCR

BM39A

Forward primer for pLlacO1 rhyB

BM40A

Reverse primer for pLlacO1 ryhB

BM41A

Forward primer for pLlacO1 micC

BM42A

Reverse primer for pLlacO1 micC

BM43A

Forward primer for pLlacO1 dsrA

BM44A

Reverse primer for pLlacO1 dsrA
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CCCAAAGCGTAAC
CGTGTTGTGAATGTTGGG
TTAAGT
AACCCACTCCCATGGTGT
GACGGGC
GTAGATGCTCATTCCATC
TCTTATGTTC
TAATACGACTCACTATAG
GGTAGATGCTCATTCC
AAAACAGGTCTGTATGAC
AACAAGTGG
TAATACGACTCACTATAG
GGTCTGGTTTCAAGATTA
GCC
AGAAAACCCCCGCACGTT
G
TAATACGACTCACTATAG
GGCTTATTCTCAGGGCG
CGTTACTCTCTCCCATCC
GGAC
GTTATATGCCTTTATTGTC
ACAG
AAAGCCCGGACGACTGTT
CG
NNCCATGGNNATAAATGT
GAGCGGATAACATTGACA
TTGTGAGCGGATAACAAG
ATACTGAGCACAAACACA
TCAGATTTCCTG
NNGAACCGGTTCNNAAAA
GCCAGCACCCGGCT
NNCCATGGNNATAAATGT
GAGCGGATAACATTGACA
TTGTGAGCGGATAACAAG
ATACTGAGCACAGTTATA
TGCCTTTATTGTC
NNGAACCGGTTCNNAAAA
AAAGCCCGGACGAC
NNCCATGGNNATAAATGT
GAGCGGATAACATTGACA
TTGTGAGCGGATAACAAG
ATACTGAGCACAGCGATC
AGGAAGACCCTC
NNGAACCGGTTCNNAAAT
CCCGACCCTGAGGG

2.4 Finding putative Hfq binding sites in IS Elements:
The following families were searched for on the IS Finder database
(http://www-is.biotoul.fr/): IS1, IS3, IS4, IS5, IS6, IS21, IS30, IS66, IS91, IS110,
IS200, IS605, IS256, IS481, IS630, IS982, IS1380, ISAs1, ISL3, Tn3, IS1595,
IS1182, IS1634, ISH3, and IS701. The search results were given as a table and
copied and pasted into Microsoft Excel. The URLs of each specific IS Element
were extracted to create lists of the URLs of all elements within a family.
WebSphinx Webcrawler (http://www.cs.cmu.edu/~rcm/websphinx/) was then
used to compile all of the URLs within each family into one concatenated
webpage saved as a text file. A Microsoft Word 2010 Macro was then used to
extract the following fields from the compiled text files: Family, Element, Hosts,
Transposition (Y or ND) IS_SEQ Comments and References, and put into a tab
delimitated excel file (see Script A1.1 in Appendix I) and more details. This
Microsoft Excel file was then searched using the SELEX site AAYAAYAA,
yielding the above results. In the database there were 3478 active links; 226 of
the IS-Elements were tested for transposition (Y) = 6.50% of submitted
sequences being actually transposing elements.
2.5 β-Galactosidase assays:
E. coli cells (NK5830F’ or its isogenic hfq- derivative DBH16) were
electroporated with transposase-LacZ translational fusions containing either an
arabinose inducible IS1413 transposase gene portion (pDH757, pDH760 or
pDH794) or an IS10 transposase gene portion (pDH662,664,668,669,703 or
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704). Transformants were grown overnight at 37°C on LB agar plates containing
ampicillin (50 μg/mL). Individual colonies were used to inoculate LB broth with
ampicillin [50 μg/mL] and grown overnight at 37°C with aeration (250 rpm).
Arabinose inducible constructs were grown either in the presence of arabinose
[0.2%] or glucose [0.2%]. Overnight cultures were subcultured by diluting
cultures 1:50 in LB broth in the absence of antibiotic and grown for 2 hours (for
hfq+ ) or 4 hours (for hfq-) at 37°C. Cultures were then placed on ice for 20
minutes. One mL of subculture was centrifuged (4000 rcm for 4 minutes),
aspirated, and resuspended in MinA broth. The turbidity of the cultures (OD600)
was recorded on a spectrophotometer (Montreal Biotech NanoPhotometer). Two
hundred and fifty μL of resuspended cells were resuspended in 250 μL of LacZ
Buffer permeablization buffer (60 mM Na2HPO4, 34 mM NH2PO4●H2O, 2.5 mM
KCl and 50 μM MgSO4●7H2O, 1% SDS, 0.3% β-mercaptoethanol). Fifty μL of
chloroform was added to each tube of permeabilized cells. Cells were lysed at
30°C for 5 minutes, followed by the addition of 100 μL of ortho-Nitrophenyl-βgalactosidase [4 mg/mL in LacZ Buffer] (this is considered the start time of the
reaction). Samples were incubated at 30°C until they took on a yellow hue after
which 250 μL of sodium carbonate [100 μg/mL] was added (this is considered the
stop point of the reaction). Samples were further incubated for 5 minutes at
30°C, centrifuged (max speed, 5 minutes) and decanted into a cuvette. The
optical density was measured for each sample at wavelength 420 nm and 550
nm. Miller units were calculated using the following equation:
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Where
t = Elapsed time from start to finish
v= volume of cells used

2.6 Hfq protein purification:
Hfq protein was purified as described in
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.

2.7 In vitro transcription and RNA labeling:
DNA templates for in vitro transcription were made via PCR. Wild type,
BM1 mutant and BM2 mutant RNA-IN run off transcription templates (bp 12221329) were prepared using a T7 RNA polymerase (RNAP) promoter containing
forward primer BM14A, BM16A or BM17A respectively. A common reverse
primer BM15A, was used for each transcript. The sRNAs GlmZ, RdlC, and SroG
run off transcription templates were prepared using the primer pairs
BM31A/BM32A, BM33A/BM34A, and BM35A/BM36A. The forward primers
BM31A, BM33A and BM35A all contain T7RNAP promoters. The resulting
amplicons were gel purified using the QIAEX II Gel Extraction kit and protocol
(Qiagen).
Run off in vitro transcription reactions consisted of 100 ng of linear DNA
template, rNTP mix {NEB) ( rATP [0.5 mM], rCTP [0.5mM], rGTP [0.5 mM]),
2.5μL of α32P- UTP [3000Ci/mMol] (PerkinElmer) 20 units of RNasin (Promega),
50 units of T7 RNA polymerase (NEB), 1X BSA (NEB), 16 μM MgCl2, 10 mM

34

DTT, inorganic pyrophosphatase [0.25U] (NEB) and T7 RNA polymerase buffer
[1x] (NEB). For in vitro transcription of unlabeled RNA, α32P- UTP was replaced
with 0.5 mM rUTP. The reaction was incubated at 37°C for 30 minutes. Two μL
of Turbo DNase (Invitrogen) was added to the reaction mixture and incubated for
another 30 minutes. The reaction mixtures were run through a BioSpin 30
column (BioRad). An equal volume of stop dye (10 mM EDTA [pH 7.5]; 97.5%
formamide (v/v); 3 mg (w/v) xylene cyanol and bromophenol blue) was added to
reaction mixtures. The reaction mixtures were then loaded on a 10% denaturing
(3M urea) polyacrylamide gel and ran at 21V/cm until the bromophenol blue dye
reached the bottom of the gel. RNA bands were cut out of the gel and eluted
overnight at 42°C in elution buffer (0.25M ammonium acetate [pH 5.8], 1 mM
EDTA [pH 8], 0.1% SDS ). The RNA was ethanol precipitated in 200 μL aliquots
by adding 8 μL of DEPC treated NaCl [5M], 1 μL of glycogen (20 mg/mL), 4 μL
EDTA (100 μM, pH 8.0), and 700 μL of 100% ethanol. Samples were incubated
at -72°C for 30 minutes, centrifuged at maximum speed for 30 minutes at 4°C,
washed twice with 70% ethanol and dried until no liquid remained (~ 5-10
minutes). RNA was resuspended in Hfq buffer (50 mM Tris [ph 7.5]; 1 mM
EDTA; 250 mM ammonium chloride; 10% glycerol)) and quantified using a
spectrophotometer (Montreal Biotech NanoPhotometer).
2.8 Electrophoretic mobility shift assays:
RNA (32P labeled or unlabelled) was thawed on ice, heated at 95°C for 2
minutes, and then immediately put back on ice. Hfq protein was diluted in Hfq
buffer to appropriate concentrations. RNA concentrations are indicated in the
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figure legends of the appropriate experiments. When two species of RNA were
being looked at simultaneously (pairing experiments), the two RNA species were
mixed together and incubated at 37°C for 15 minutes.

For competition

experiments, Hfq was preincubated with the competitor RNA (dsrA or polyA16) for
10 minutes at room temperature followed by the addition of RNA-IN for an
additional 10 minute incubation at room temperature. For EMSAs looking at only
one RNA species, Hfq the RNA were incubated for 10 minutes at room
temperature together in 10 μL. Binding reaction mixes had load mix added (20
mM Tris-HCl pH 7.5, 10 mM DTT, 100 mM KCl, 30% glycerol; 0.05% w/v
bromophenol blue) and were loaded onto a 6% native polyacrylamide gel. Gels
were run at 21V/cm until the bromophenol blue ran to the bottom. The gel was
then dried, and analyzed using a Phosphoimager (Storm 860 Scanner) and
ImageQuant software (GE Life Sciences).

2.9 RNA-sRNA basepairing predictions:
The sRNA map database 69 was downloaded from
(http://srnamap.mbc.nctu.edu.tw/download.php). The sRNA sequences were
then merged into one file using MS-DOS’s copy function. The resulting text file
was used as the source of RNA sequences and was pasted into the ncRNA field
of IntaRNA; IS10 transposase DNA sequence was then pasted into the mRNA
field of IntaRNA. The results table from INTARNA was copied into MS-Excel
2010, and sorted according to the stability of the resulting paired species
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between the mRNA and sRNA. The parameters set for IntaRNA were: 37°C and
a minimum seed region of 7 basepairs.
2.10 3’ RNA ligase-mediated rapid amplification of cDNA ends (3’ RLMRACE):
Three prime RLM-RACE was conducted as described in 70. NK5830 F’
cells containing the Tn10 containing plasmid pBE10 was grown to exponential
phase (OD600 = 0.6) in LB broth containing tetracycline [10 μg/mL]. Cells were
grown at 37°C with aeration. Total cellular RNA of the Tn10 expressing NK5830
F’ cells was extracted using the RNEasy kit (Qiagen) according to manufacturer’s
protocol. The RNA ligation reaction mixture contained: 2 μg of total cellular
RNA,T4 RNA Ligase Buffer (1X, NEB), DMSO (10% v/v), 20 U of RNAsin
(Promega), RNA adapter BM21A [1.5 ng/μL], 20 units of T4 RNA ligase (NEB),
and DEPC H2O to bring the reaction mixture volume to 50 μL. The RNA ligation
mixture was incubated for 1 hour at 37°C and then cleaned up using the RNEasy
kit (Qiagen) eluted in 30 μL of RNase free H2O. The RNA was then subjected to
reverse transcription PCR. Five μL of each sample containing the ligated RNA
adapter was mixed with2 μL of BM19A [20 μM] and 4.5 μL of nuclease free H2O.
The reactions were heated to 75°C for 5 minutes and then immediately cooled on
ice. To the reaction mix, 1 μL of Moloney Murine Leukemia Virus Reverse
Transcriptase (M-MuLV RT) [200000 units/mL] (NEB), 5 μL of dNTP mix [10 mM],
2 μL of M-MuLV RT Buffer [10x] (NEB) and 0.5 μL of RNasin inhibitor was added.
The reverse transcription reaction was incubated at 25°C for 5 minutes, 37°C for
1 hour, and 72°C for 10 minutes. Reaction mixtures were put through a PCR
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clean up column (Qiagen) and eluted in 30 μL of nuclease free H2O. The
resulting cDNA mixture underwent a nested PCR reaction. For the first reaction 5
μL of cDNA was mixed with 1.25 μL of primers BM8A/BM19A [20 μM each], 5 μL
H2O and 12.5 μL of GoTaq Master Mix (Promega) [2X]. PCR cycling parameters
were as follows: 98°C for 2 minutes for an initial denaturing, followed by 10 cycles
of 98°C for 30 seconds, 64.5°C for 40 seconds, and 72°C for 2 minutes. The
PCR mixture (mix 1) was diluted with 180 μL of ddH2O. This diluted mix 1 was
then used for a second round of amplification consisting of 5 μL of diluted mix,
1.25 μL of primers BM9A/BM20A [20 μM each], 5 μL of H2O and 12.5 μL of
GoTaq Master Mix (Promega). PCR cycling parameters were as follows: 98°C
for 2 minutes for an initial denaturing, followed by 30 cycles of 98°C for 30
seconds, 68°C for 40 seconds, and 72°C for 2 minutes. A final extension step
was performed at 72°C for 5 minutes. The PCR amplicons were gel purified
using the QIAEX II Gel Extraction Kit (Qiagen) according to the manufacturer’s
protocol. Gel extracted amplicons were cloned into the T-vector pGEM-T-EASY
(Promega) and used for electroporation of DH5α electrocompetent E.coli cells.
Plasmids were extracted from individual clones using the GenElute™ Plasmid
Miniprep Kit (Sigma-Aldrich) and sent for sequencing using primer BM9A.
2.11 Western blots:
For Hfq semi-quantification in NK5830 F’ cells and its rpoS- isogenic
derivative in the mating out assays, individual colonies were grown in LB broth
containing kanamycin [25 μg/mL] in conditions identical to the mating out assay.
Three mL of cell cultures were centrifuged (1 min, maximum speed) and
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resuspended in 20 μL of 1X Laemmli load dye and boiled for 5 minutes. Cell
lysate was briefly centrifuged to collect lipids to the bottom of the tube. Ten μL of
supernatant was loaded on a 12% Tricine SDS Polyacrylamide gel. Samples
were run at 100V on the Mini-Protean II system (BIO-RAD) with 1X tricine buffer
(0.1 M Tris, 0.1 M tricine and 0.1% SDS) until the samples passed through the
stacking gel. The voltage was then increased to 150V and run until the
bromophenol blue dye front reached the bottom of the gel. Proteins were
transferred to a PVDF membrane (45 mA for 40 minutes). Hfq was detected
using a rabbit polyclonal Hfq antibody (diluted 1:100,000 in 2.5% powdered nonfat milk (Nelson) in TBST (2 mM Tris pH7.5, 0.5% Tween-20, 15 mM NaCl)) and
a Goat Anti-Rabbit IgG (H+L), conjugated to horseradish peroxidase (1:4000
dilution in 2.5% powdered non-fat milk (Nelson) in TBST) (Pierce). PVDF
membranes were imaged using the Storm 860 Scanner. PVDF membranes were
then stained by Coomassie stain, and a picture was obtained for sample
normalization on an Alpha Imager. Western blot and coomassie images were
analyzed for band intensity using ImageJ software (NIH).
2.12 Verification of sRNA induction:

Plasmids containing IPTG inducible sRNAs (pDH694-696, pDH673), were
verified to induce via IPTG by extracting RNA from NK5830F’ E. coli in the
presence or absence of IPTG RNA was extracted from exponentially growing
NK5830F’ cells (OD600=0.6) and isolated using the hot phenol extraction method
as described in 71. RNA was quantified using a spectrophotometer and RNA
purity was ensured by ensuring an OD260/280 ratio of ≥1.8 and an
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OD260/OD230 ratio ≥1.5. RNA samples were also checked for integrity by
resolving 5S, 16S and 23S ribosomal RNA molecules on a 1% agarose gel.
Reverse transcription PCR was performed using M-MuLV reverse transcriptase
(NEB), Taq DNA polymerase (Promega), 1 μg of cellular RNA and primers
BM37A/BM38A [2 μM each] for MicC and BM30A/BM32A [2 μM each] for GlmZ.
The primer pairs for 16S rRNA were BM28A/BM29A. PCR was performed for
MicC using the following parameters: 98°C, 30 s; 55°C, 45 s; 72°C, 60 s and
cycled 19 times. The 16S rRNA PCR parameters are the same as above except
that the annealing temperature was 62°C and cycled 7 times. The GlmZ PCR
parameters were the same as above except the annealing temperature 60°C and
cycled 11 times. To ensure PCR was within linear range, 2 more subsequent
PCR cycles were done on each transcript (1 at a time) and the resulting amplicon
approximately doubled in intensity.
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Chapter 3 - Results
3.1 How common is the Hfq mediated repression of transposase expression
in IS Elements?
Hfq is negative regulator of transposase gene expression in both IS10 and
IS50 elements 18,51. In this work I asked the question of how common is it for a
transposase to be regulated by Hfq? To start addressing this question, I had to
devise a method of how to systematically identify known IS Elements for potential
Hfq regulation. One method of doing this would be to individually clone random
IS Elements into an expression vector and look at either transposase expression
levels or transposition frequencies in the presence or absence of Hfq. One issue
with this method is the possibility that it may be difficult to express IS Elements
from certain organisms in E.coli. To overcome this expression issue, a collection
of different bacterial species with the appropriate hfq gene disruptions would be
required. The other issue is that some of these species may require growth
media and conditions that cannot be achieved with the equipment available in the
laboratory. To prevent these possible technical difficulties, I chose to search the
IS Finder database 72 for transposase genes that contain putative Hfq binding
sites to give a list of candidates that may be Hfq regulated. This list is a starting
point to determine which elements to then test for transposition activity in the
presence and absence of Hfq. A possible caveat of this approach is that it is
using Hfq binding motifs determined for E. coli Hfq. The possibility remains that
other organisms' Hfq may have different binding preferences. Studies have been
done on how effective interspecies Hfq can complement Hfq deletions in E.coli.
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One can presume that if a xenotropic hfq gene can complement an hfq deletion
mutant, the two proteins are acting in similar manner. A study by Schilling et al,
shows that one can complement an E.coli strain MC4100 AM111 hfq deletion
with the hfq gene from Acinetobacter baylyi to relieve the slow growth phenotype
in LB media. In the Acinetobacter case, the Hfq protein is larger than the E.coli
homologue (174 amino acids verses 102 amino acids respectively) with an
elongated glycine rich C-terminus73, yet still can complement the growth defects
of an E. coli Hfq deletion. Another study by Sonnleitner et al. involving
Pseudomonas aeruginosa rpoS gene activation (which is an Hfq dependent
process), showed that Pseudomas' Hfq can functionally complement rpoS gene
activation defects in hfq disruption strains of E.coli. RpoS gene activation and
rpoS independent pathways that are affected by Hfq deletions were all restored
when expressing the Pseudomonas Hfq homolog in E.coli

74

. This database

searching strategy is a little more simplified than the successful approaches used
for sRNA discovery that consist often of searching intergenic regions of bacterial
genomes for orphan promoters. For example, a study by Chen et al. searched
E.coli intergenic regions for genes between a σ70 promoter and a Rhoindependent terminator. These searches resulted in 227 candidates to be sRNA
genes 75.
The goal of my bioinformatics approach was to identify potential Hfq
binding sites in IS Elements which may imply binding to and regulation of the
element. To do this, all IS Elements submitted to the IS Finder database 72 were
compiled into a series of files which were then searched for the two Hfq binding
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sequences AAYAAYAA and AYAATAA. These consensus sequences were
identified by Lorenz et al in a genomic SELEX screen for Hfq binding RNAs 44,
and are consistent with the ARNx motif of Hfq previously identified by Link et al to
bind the distal face 41. It is important to note that Hfq binding is sequence and
structurally dependent. Hfq often binds motifs consisting of U rich regions
upstream of a single or double hairpin 76. The IS Finder database contained
3478 active IS entries (as of February 2011). Of these 3478 entries only 226 of
the entries were actually tested to be active IS Elements. Both AAYAAYAA and
AYAATAA motifs were found at a variety of positions within the IS Elements'
transposase transcripts. For the AAYAAYAA motif, 3 of the motifs are in the 5'
region of the transcripts, 7 of the motifs are in the middle region of the transcripts,
and 5 of the motifs are in the 3' region of the transcripts (Table 3.1) for a total of
14 identified sequences. The family distribution of AAYAAYAA containing IS
Element transposases' include IS3, IS4, IS21, IS30, IS256 and lSl3. For the
AYAATAA motif, 6 of the motifs are in the 5' region of the transcripts, 6 of the
motifs are in the middle region of the transcripts, and 6 of the motifs are in the 3'
region of the transcripts (Table 3.2) for a total of 18 identified sequences. The
family distribution of AYAATAA containing IS element transposases include IS3,
IS4, IS5, IS21, IS30, IS110, IS630, and IS1380. Since, IS Elements have
different DNA base compositions, I also calculated what the probability of finding
the number of SELEX sites in each element based on their length and DNA base
composition. The binomial cumulative distribution function of Microsoft Excel
2010 was used to calculate the probability of finding exactly the number of
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putative Hfq binding sites that were reported in each element (See Appendix I for
sample calculations.)
Using this bioinformatics approach, I have identified 32 IS Element
transposase genes that may be under the regulation of Hfq using putative Hfq
binding sites. This provides a list of IS Element transposase genes that are
candidates for further characterization of their regulatory sequences and
interactions with Hfq.
3.2 Hfq regulation of IS1413:
To verify the effectiveness of my bioinformatics search to predict Hfq
regulation in IS Elements the effect of Hfq on IS1413 transposase expression
was tested. Our fourth year honours student Morgan Black used my
bioinformatics analysis as the basis to perform electrophoretic mobility assays
(EMSA) to demonstrate that both E.coli and Burkholderia Hfq bind IS1413's
transposase transcript in vitro. She also showed using an IS1413 transposaseLacZ translational fusion, that the expression of the IS1413 transposase is 17.8
fold higher in hfq-- E.coli cells than in E.coli cells encoding a functional hfq gene.
In this section of the thesis I address 2 questions arising from Morgan's initial
observations:
1. Is the Hfq repression of IS1413 transposase expression dependent on the
AAYAAYAA sequence found in the 5' UTR?
2. Does Hfq repress IS1413 transposition in E.coli
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Table 3.1 Elements in the IS Finder database containing the predicted Hfq binding sequence AAYAAYAA.
IS Elements were merged into one file from the IS Finder Database (http://www-is.biotoul.fr/) utilizing the
WebCrawler Web Sphinx 77. Relevant fields were extracted utilizing the find and replace functions in Microsoft
Word 2010, and finally the location of the SELEX defined Hfq binding site was determined. This information is
current as of February 2011. The P-Value represents the probability that one would find exactly the number of
binding sites found for the given element (the probability mass function) and was calculated using Microsoft Excel
2010. A probability of 1 would represent a SELEX site that is probably unimportant; as it appears the number of
times one would expect it to. A probability of 0 would represent a SELEX site that you would expect to see either
much more or less than one observed. See Appendix I for P-value calculations. SELEX Locations are denoted in
the far right column preceded by the number of SELEX sites found in the IS Element’s transposase mRNA
sequence.
IS Family

IS Element
IS1223
IS1550
IS199
ISMmy2
IS10R
IS186A
IS186B
IS21
IS232A

Length
bp
1494
1408
1220
1374
1329
1341
1338
2131
2184

GC
Content
32%
24%
43%
28%
44%
51%
51%
52%
34%

IS3
IS3
IS3
IS3
IS4
IS4
IS4
IS21
IS21
IS21
IS30
IS256
IS256
IsL3

P-Value

Organism

SELEX Location

3.23x10
-2
6.81x10
-1
1.38x10
-1
3.54x10
-1
1.36x10
-2
6.71x10
-2
6.70x10
-2
9.17x10
-2
2.86x10

-1

Lactobacillus johnsonii
Mycoplasma fermentans
Streptococcus mutans
Mycoplasma mycoides
Salmonella typhimurium
Escherichia coli
Escherichia coli
Pseudomonas aeruginosa
Bacillus thuringiensis

-1

Escherichia coli
Corynebacterium glutamicum
Burkholderia phenoltripix
Lactococcus lactis
Staphlococcus aureus

(1) Middle
(3) Middle
(1) 5’ end UTR
(1) 3’ end
(1) 3’ end
(1) 3’ end
(1) 3’ end
(1) Middle
(1) Middle
(2) 5’ end of ORF2
(1) Middle
(1) Middle
(1) 5’ UTR
(1) Middle
(2) 3’ end

ISEc12
ISCg2
IS1413
IS905A
IS1181

2484
1636
1428
1313
1513

48%
53%
60%
38%
32%

1.58x10
-2
6.40x10
-2
2.22x10
-1
2.17x10
-2
9.45x10
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Table 3.2 Elements in the IS Finder database containing the predicted Hfq binding sequence AYAATAA. IS
Elements were merged into one file from the IS Finder Database (http://www-is.biotoul.fr/) utilizing the webcrawler
Web Sphinx 77. Relevant fields were extracted utilizing the find and replace functions in Microsoft Word 2010, and
finally the location of the SELEX defined Hfq binding site was determined. This information is current as of
February 2011. The P-Value represents the probability that one would find exactly the number of binding sites
found for the given element (the probability mass function) and was calculated using Microsoft Excel 2010. A
probability of 1 would represent a SELEX site that is probably unimportant; as it appears the number of times one
would expect it to. A probability of 0 would represent a SELEX site that you would expect to see either much more
or less than one observed. See Appendix I for P-value calculations. SELEX Locations are denoted in the far right
column preceded by the number of SELEX sites found in the IS Element’s transposase mRNA sequence.
IS Family

IS Element

Length (bp)

GC
Content

P-Value

Organism

IS3
IS3
IS3

IS1138
IS1520
IS1550

1288
1302
1408

23%
38%
24%

2.59E-01
3.24E-01
1.00E-01

Mycoplasma pulmonis
Lactobacillus sakei
Mycoplasma fermentans

IS3

ISMmy2

1374

28%

3.36E-01

Mycoplasma mycoides

IS4
IS4
IS4
IS5
IS5
IS21
IS30
IS30

IS10R
IS4Bsu1
ISBth4
IS903B
ISC1058
IS232A
ISAs2
ISCg2

1329
1406
2024
1057
1058
2184
1084
1636

44%
40%
35%
53%
43%
34%
59%
53%

2.32E-01
3.06E-01
3.62E-01
8.09E-02
2.13E-01
3.45E-01
3.84E-02
1.20E-01

IS110
IS630
IS1380

IS492
IS630
IS942

1202
1153
1598

42%
52%
40%

2.49E-01
9.82E-02
3.25E-01

IS1380
IsH3
IsL3

ISEc9
ISC1439A
IS1181

1656
1439
1513

33%
39.00%
32.00%

3.63E-1
3.24E-01
2.11E-01

Salmonella typhimurium
Bacillus subtilis
Bacillus thuringiensis
Escherichia coli
Sulfolobus solfataricus
Bacillus thuringiensis
Aeromonas salmonicida
Corynebacterium
glutamicum
Pseudomonas atlantica
Shigella sonnei
Bacteroides fragilis
TAL3636
Escherichia coli
Sulfolobus solfataricus PH1
Staphylococcus aureus
BM3121
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SELEX Location
(1) 3’ end
(1) 5’ UTR
(3) Middle
(1) 3’ end
(1) 3’ end
(1) 3’ end
(1) 5’ UTR
(1) 5’ UTR
(1) 5’ end
(1) Middle
(1) Middle of ORF 1
(1) 5’ UTR
(1) Middle
(1) 5’ UTR
(1) 3’ end
(1) 3’ UTR
(1) Middle
(1) 3’ end
(1) Middle
(1) 3’ End

To address the first question, two mutations were made in the SELEX site
of IS1413's transposase gene. Mutations were made to disrupt the SELEX site
or secondary structure around the SELEX site. Amino acid changes or codon
bias was not considered in these mutations, as the SELEX site is in the 5' UTR of
IS1413 transposase. Mutant B contained an adenine to a guanine mutation at
position 108 and an adenine to a cytosine mutation at position 113 (Figure 3.1 B,
sequence B). Mutant C contained a cytosine to thymine mutation at position 107
and an adenine to a thymine mutation at position 112 (Figure 3.1 B, sequence
C). To determine the effect of IS1413 transposase's SELEX site mutations on
Hfq regulation, transposase expression was determined in cells containing an
intact hfq gene as well as isogenic cells containing an hfq disruption.
Transposase expression was measured through the use of transposase-LacZ
translational fusions. The first 445 base pairs of IS1413 and the two mutants
were fused to the sequence encoding the ninth codon of LacZ. These mutants,
as well as the wild type sequence were then put under control of an arabinose
inducible promoter (p-Ara) to increase transcription and transposase expression
was tested in both hfq+ and hfq- backgrounds. For the wild type construct, there
is a 3 fold increase in expression (i.e. β-galactosidase activity) in hfq- cells when
comparing isogenic hfq+ and hfq- strains (Figure 3.1A). In comparison, both
mutant constructs gave an increase in transposase expression of around 10-fold
in both genetic backgrounds (Figure 3.1A). An increase of transposase
expression in the mutant constructs was surprising, as the hypothesis predicted
that there only should have been an increase in activity in hfq+ cells. The overall
increase in transposase expression may be explained by the mutations providing
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a better ribosome binding site than the wild type sequence. To date, the actual
ribosome binding site of IS1413 has not been characterized, but it would likely be
around the proximity of the SELEX site. Another possibility is the mutations may
increase either steady state levels of the transcript or increase the half-life of the
transcript. Mutant B shows a 3 fold increase in activity in the hfq- strain relative to
the hfq+ strain (Figure 3.1A). Mutant C shows a 1.5 fold increase in activity in
the hfq- strain relative to the hfq+ strain. Overall, Hfq has an effect on expression
of IS1413, however, more mutant forms of IS1413 will have to be tested to hone
into the sequence that Hfq is potentially binding to. There is a possibility that
other Hfq binding sites may exist in other regions of the IS1413 transposase
transcript which may be the reason why mutation analysis did not abolish Hfq
repression. Another possibility is that the Hfq effect is actually indirect. For
example, Hfq is a known regulator of many genes within bacteria such as rpoS (a
gene encoding a sigma factor often associated with stress responses) 78, and it
could be a gene under RpoS' control that is the cause of the increased
transposase expression in hfq- cells. These remain possible avenues for future
investigation.
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Figure 3.1 β-galactosidase activity for IS1413-LacZ translational fusions.
Translational fusions were transformed into NK5830 F’ (Hfq+) or its isogenic Hfqderivative and Miller assays were performed. This data shows the means and
standard deviations of at least 2 independent experiments. B. Mutations were
made in the putative Hfq binding region (SELEX) of the IS1413 LacZ fusion under
the control of an arabinose inducible promoter. Construct A shows the wild type
sequence of 1413. Sequence B and C show the mutations made, with the
affected nucleotide highlighted in red. C. A schematic of the 1413-LacZ portion
of the β-galactosidase construct.
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To test the transposase activity of IS1413 in E. coli and to determine if the
Hfq status affects the activity, a 'marked' IS1413 element (IS1413-Kan) was
made by inserting a kanamycin resistance gene between the stop codon of the
transposase and the adjacent transposase end of IS1413 (see Materials and
Methods). NK5830 F' cells were transformed with a plasmid containing IS1413Kan and a mating out assay was performed (see Materials and Methods).
Briefly, the mating out assay involves transforming Hfq+ or Hfq- NK5830 F' E.coli
cells (Arg-/F' laciq L8 pro) with a plasmid containing a kanamycin ‘marked’ IS1413
element. Transformants (donors) and HB101 (leu-, strR, F-) cells (recipients) were
grown overnight on LB agar with kanamycin or LB agar with streptomycin
respectively at 37°C. Individual colonies of donors were used to inoculate LB
broth containing kanamycin and grown overnight at 37°C with aeration (250 rpm).
Individual recipient colonies were also picked and grown overnight at 37°C with
aeration (250 rpm) in LB broth containing streptomycin. Overnight cultures of
donors and recipients were individually subcultured into selection free LB media.
Donors were grown for 2 hours (4 hours for Hfq-) at 250 rpm at 37°C, then culture
tubes were transferred to a slower aerator at about 50 rpm to facilitate sex piIIi
formation for 2 hours (4 hours for Hfq-) . Recipient cells were grown for 4 hours
at 37°C at 250 rpm. Recipient and donor cells were mixed together at a 5:2 ratio
and allowed to undergo conjugation for 1 hour at 37°C at 50 rpm. Cell mixtures
were then vortexed, centrifuged (4000 rcm, 4 minutes), and resuspended in
0.85% saline. To determine the number of successful transfers through
conjugation of the F-factor (which can be tracked by the proline gene), cells were
plated on M9 agar plates containing glucose, streptomycin, leucine and thiamine.
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The number of transposition events is measured by selecting for cells that have
had the marked IS1413 element transpose onto the F-factor. Recipients
containing the F-factor with an IS1413 element are selected for by plating on M9
agar plates containing glucose, streptomycin, kanamycin, leucine and thiamine.
The transposition frequency of IS1413 is calculated by dividing the number of
IS1413 transposition events by the total number of successful F-factor transfers.
IS1413 has an average transposition frequency in NK5830 F’ E.coli cells of 3.7 x
10-5 ± 7.8 x 10-5 transposition events per mL of mating mix (in the presence of
Hfq) and 5.0 X 10-4 ± 3.8 X 10-4 transposition events per mL of mating mix (in the
absence of Hfq) (Figure 3.2). Thus, Hfq has a repressive effect on IS1413
transposition, down regulating transposition events by approximately 13 fold.
When comparing the medians of the two conditions, the trend of Hfq repression
continues. The median of IS1413 transposition frequency in an Hfq+ background
being 7.85 x10-6 and the median of IS1413 transposition frequency in an Hfqbackground being 4.85 x 10-4 resulting in a 61.7 fold increase (by median) of
IS1413 transposition frequency in hfq- cells relative to hfq+.
3.3 Alternative pathways of IS10 regulation by Hfq at the 3' end of the
mRNA transcript.
The 3' region of IS10 transposase also contains the AAYAAYAA motif as
identified in section 3.1. Most regulatory studies of IS10 have been focused on
the 5' region of the transposase gene. Hfq has already been established as a
negative regulator of IS10 transposition 18. This section of the thesis explores the
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potential contribution the IS10 transposase’s 3' putative Hfq binding site has in
Hfq repression.
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Figure 3.2 Hfq represses IS1413 transposition. NK5830 F’ and its Hfqisogenic strain (DBH16) was transformed with a plasmid containing a kanamycin
marked IS1413 element and grown overnight on LB medium with kanamycin [25
μg/mL]. Cells were subcultured in LB to an OD600 of ~ 0.6 and the mating out
procedure was followed. Total exconjugates and total hops were calculated and
transposition frequencies were calculated by dividing the total hops by the total
exconjugates. This data shows the means and standard deviations from 2
independent experiments both with n=4.
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One proposed mechanism of Hfq regulation on IS10, is that Hfq
accelerates the pairing of RNA-IN and RNA-OUT (see introduction) 18. One issue
still remains with this proposed mechanism; when you disrupt hfq in a cell
harbouring a single copy of IS10 (where the effect of RNA-OUT is thought to be
negligible), Hfq still exhibits a repressive effect on IS10 transposition 18. An
observation from our laboratory technician, Ryan Trussler, is that transposase
mRNA stability increases in the absence of Hfq. The half-life of RNA-IN in the
presence of Hfq is 0.79 minutes versus 1.1 minutes in the absence of Hfq. These
observations suggest that Hfq plays a role in the stability of RNA-IN. There are at
least two known mechanisms for how Hfq can alter the stability of RNA.
Polyadenylation of mRNA by poly(A) polymerase I (PAP) in E. coli is stimulated
by Hfq. In vivo, hfq gene deletions result in shorter polyA tails on the rpoS mRNA
transcript 79. Polynucleotide phosphorylase (PNP), is an 3 '  5' exonuclease
that preferentially degrades RNA with 3' polyadenylated or polyurindinylated tails
in vitro 80. Taken together, these observations suggest that Hfq can facilitate the
polyadenylation of RNA transcripts resulting in polynucleotide phosphorylase
mediated degradation 81. Another Hfq mediated RNA degradation mechanism
involves Hfq, sRNAs, and RNase E. Morita et al demonstrated that RNase E copurifies with Hfq. They also showed that Hfq in conjunction with an sRNA (in
their case RhyB) is able to target the RNase E-Hfq complex to a target mRNA
(sodB) resulting in mRNA degradation 81. I sought to determine if Hfq is working
through either of these two mechanisms to promote IS10 mRNA turnover.
Hfq binding sites on the 3' end of mRNA transcripts have been associated
with promoting the turnover of mRNA transcripts through increased
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polyadenylation which facilitates PNP-dependent degradation. Since this
mechanism depends on the transcript of interest to contain a polyadenylated tail,
I sought to define the 3' end of the IS10 transcript and establish the presence or
absence of a polyA tail. The transcriptional stop points of IS10 transposase have
not previously been defined, nor has it been established if a polyA tail is present
on the transcript. I employed the 3' RLM-RACE technique to analyze the 3' end
of the IS10 transposase transcript. The source of transposase RNA for this
experiment was a plasmid (pBE10) encoding the Tn10 transposase. Cells
containing pBE10 were grown to exponential phase (OD600 ~ 0.6). Total cellular
RNA was isolated and a RNA-adaptor (BM21A)
(GTGATGGGCGATGAATGAACACTGCGTT) was ligated to the total cellular
RNA molecules using T4 RNA Ligase (NEB). RNA underwent reverse
transcription, followed by a nested PCR reaction. Briefly, the nested PCR
reaction consisted of the first PCR reaction using primers BM8A and BM19A for
10 cycles of amplification. This first PCR reaction was diluted ten-fold in H20 and
then 5 μL of the first round of amplification was used as a template for the second
round of amplification. The second round of PCR amplification used primers
BM9A and BM20A which anneal closer together than primers BM8A and BM19A
to reduce the chance of non-specific amplification. The second round of PCR
amplification was done for 30 cycles. Specific details of the PCR reactions are
described in the Materials and Methods section. PCR products were run out on
an agarose gel, gel purified, cloned into the pGEM T-easy vector (Promega) and
transformed into DH5α. A total of 51 clones were sent for sequencing. Twentyseven of the clones had IS10R sequence, 13 of the clones had IS10L sequence
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and 11 of the clones did not contain IS10 sequence. Analysis of the IS10R
sequences reveals a favoured transcription stop point in the tetD gene at bp 7718
(relative to bp 1 of Tn10) with no signs of polyadenylation (Figure 3.3). Analysis
of the IS10L sequences shows that there appears to be a favoured transcription
stop site upstream of the jemA gene at bp 2750 relative to bp 1 of Tn10 and no
polyadenylation.
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Structure of Tn10 Transposase
IS10L

jem A

jem B

jem C

tet R

tet A

tet C

tet D

IS10R

3’ RLM-RACE Alignment of IS10R Sequences

3’ RLM-RACE Alignment of IS10L Sequences

Figure 3.3 Three prime RLM-RACE studies show that IS10 transcripts from Tn10
have defined stop points, with no indication of polyadenylation or Rhoindependent termination sequences. Total RNA was isolated from NK5830F’ cells
expressing Tn10. Complementary DNA was synthesized using M-MLV Reverse
Transcriptase (NEB) and IS10 mRNA was PCR amplfied. PCR amplicons were
cloned into pGEM T-Easy vector (Promega) and sequenced. Sequences were aligned
and compared in MS Word 2010.
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Overall IS10 has a defined transcriptional stop with no indications of a Rho
independent terminator (verified by ARNold terminator predictor 82). There is also
no polyadenylation of the IS10 transcript. Interestingly, there is a predicted Rho
dependent terminator early on in the IS10 (L/R) transcript at bps 357-396 relative
to the Tn10 DNA sequence with a predicted stability of -9 Kcal/mol (ARNold
terminator predictor) 82, which would not be picked up with the primers used in
this method. With the absence of any polyadenylation on the IS10 transposase
mRNA, it is unlikely that the reduced half-life in the presence of Hfq is due to
neither the recruitment of PAP nor the PNPase degradation pathway. The HfqRNase E mediated degradation of IS10 transposase mRNA still remains a
possibility and is explored in the next section.
3.4 Does Hfq bind the 3' end of IS10?
Absence of polyadenylation on the IS10 transposase mRNA rules out the
PAP-PNP model of RNA degradation. I considered the alternative model that an
Hfq-RNase E complex might bind the 3' end of the IS10 transposase transcript
resulting in the degradation of the mRNA. I sought to determine if Hfq is actually
able to bind the 3' end of the IS10 transcript. Furthermore, since this mechanism
of RNA degradation would be disrupted if Hfq was unable to bind the transcript, I
looked at the effects of mutating the putative Hfq binding site. The 3' region of
RNA-IN (bp 1222-1329) was PCR amplified with a T7 promoter included in the
forward primer (see Figure 3.4). This amplicon was used as a template for ‘run
off’ in vitro transcription using T7 RNA polymerase and rNTPs including 32P αCTP.
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Figure 3.4 In vitro transcription schematic. A T7 RNA Polymerase (RNAP)
promoter is incorporated in a forward primer for PCR amplification of the gene of
interest. After purification of the PCR amplicon, T7 RNA Polymerase is incubated
with rNTPs (including 32P labelled rUTP) to make the resulting radio-labelled RNA
molecule. Unlabelled RNA molecules can be made by substituting the 32P
labelled rUTP with an unlabelled version.
Labelled RNA was isolated by loading on a 10% denaturing polyacrylamide and
the prominent RNA species was cut out and eluted overnight in elution buffer.
Eluted RNA was tested for purity by spectrophotometer and integrity on another
10% denaturing polyacrylamide gel. RNA preparations were quality controlled to
ensure they gave a clean band on the denaturing gel. Hfq binding was
determined by EMSA. Competition assays were used to follow up initial Hfq
binding assays to define which face of Hfq the 3’ end of IS10 transposase mRNA
and its mutants bind. DsrA is a sRNA known to bind the proximal face of Hfq and
polyA RNAs bind Hfq at the distal face 83. By preincubating Hfq with either DsrA
or polyA16 RNA and then adding the 3’ end of the IS10 transposase mRNA, we
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can determine if there is any competition for Hfq binding sites. Competition for
Hfq binding provides evidence of which face the non-competing RNA is binding.
For example, if one is unable to see a displacement of DsrA from Hfq, even in
very high concentrations of RNA-IN, it is very likely that RNA-IN binds the distal
face instead of the proximal face (where DsrA is) of Hfq. Knowing which face of
Hfq the 3’ end of RNA-IN binds, may help us elucidate possible roles the RNAHfq complex may have in the cell. For example, if the 3’ end of RNA-IN binds the
proximal site of Hfq (similar to how the 5’ end binds), a potential explanation for
its role could be that it chelates out Hfq from acting on the 5’ end of the transcript
(see Discussion).
The wild type sequence is predicted by Mfold 84 to form a stem loop right
before and after the SELEX site (Figure 3.5A). Hfq binds RNA-IN 3’ with an
approximate KD between 6.08 and 12 nM, as suggested by over 50% of free RNA
being bound by Hfq between Hfq concentrations of 6.08 nM and 12 nM (Figure
3.6A +B). The wild type sequence binds Hfq presumably on the proximal site as
shown by it outcompeting DsrA (an sRNA known to bind the proximal sites of
Hfq) in competition studies until DsrA is in 25 fold excess to RNA-IN (Figure
3.7A).
To test the specificity of the Hfq binding site on the 3' end of RNA-IN
mutant, I looked at two different mutations. Since I eventually wanted to look at
the effect of Hfq binding disruption in vivo, mutations were constrained to be
silent and have little effect on codon bias in E. coli. I also considered potential
positions around the SELEX site that may affect the secondary structure context
of the site.
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Figure 3.5 The proposed structure for each of the RNA-IN 3’ species. RNA
structures were predicted using Mfold 84 and their predicted stabilities are noted
within the structures. The proposed Hfq binding site is highlighted in yellow and
any mutations are highlighted in red A. RNA-IN 3’ (WT). B. RNA-IN 3’ (BM1) C.
RNA-IN 3’ (BM2)

The first mutant BM1 has a C1229T mutation (found just outside of the
SELEX site) and an A1239C mutation (which disrupts the last A of the
AAYAAYAA motif to a C). The BM1 mutant has its modified SELEX site on a
predicted single stranded region close to an RNA-hairpin (Figure 3.5B shown
with changed bases highlighted in red). The BM1 mutation resulted in an
increase in apparent KD relative to the WT sequence, with an approximate KD
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between 314-614 nM (Figure 3.6C). The BM1 mutated RNA-IN likely binds the
proximal site of Hfq due to the inability of polyA16 RNA (an RNA known to bind
the distal site of Hfq) to outcompete the RNA-Hfq complex 2 formation at a 4.3
fold excess. DsrA starts to compete with RNA-IN 3' BM1 at a 4.3 fold excess, as
shown by the loss of RNA-IN 3' BM1 Complex II (Figure 3.7B).
The RNA-IN 3' mutant BM2 has an A1232G mutation; (mutates the first A
of the AAYAAYAA motif to a G) and an A1238G (mutates the second last A of the
AAYAAYAA Motif to a G). The BM2 mutant has its modified SELEX site on a
predicted single stranded region between 2 hairpins (shown in Figure 3.5C with
changed bases highlighted in red), has its modified SELEX site on a single
stranded region flanked directly by 2 hairpins and on an extend arm compared to
the other two RNA species. The BM2 mutation resulted in an apparent KD
between 80-160 nM (Figure 3.6D). RNA-IN 3' BM2 appears to bind the distal
side of Hfq, suggested by the competition with only a 0.5 excess of polyA 16 and
no competition with DsrA at a 10 fold excess (Figure 3.7C). Hfq does specifically
bind the 3' region of RNA-IN, and this specificity is sequence and possibly
structurally dependent (based on mfold predictions) as shown by the modulation
of binding affinity through the BM1 and BM2 mutations.
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Figure 3.6 Hfq binds the last 107 nucleotides of IS10 and mutating the
SELEX site reduces binding. 32P labelled RNA-IN 3’ and its mutants were
mixed with varying Hfq concentrations and incubated at room temperature for 10
minutes. Reactions were resolved on a 6% native polyacrylamide gel. [RNAIN3’] = 1.52 nM/Reaction, [BM1] = 3.45 nM/Reaction, [BM2] = 2.15 nM/Reaction.
B. The binding curve of Hfq-3’ RNA-IN was plotted using Prism 5.0 software and
fit to the equation Y=Bmax*X/ (Kd + X). Where Y = % of 3’ RNA-IN bound to Hfq,
Bmax = the minimum concentration of Hfq in which 100% of 3’ RNA-IN is bound,
X = the concentration of Hfq, and KD = the concentration of Hfq1 (in nanomoles/L)
where 50% of 3’ RNA-IN is bound.
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Figure 3.7 Hfq binds the last 107 nucleotides of IS10 and binding can be
competed using the proximal binding sRNA DsrA or the distal binding
polyA16 RNA. A. 32P labelled RNA-IN 3’ [1.52 nM/reaction] and was mixed with
varying concentrations ( 0.154 nM, 0.308 nM, 0.616 nM, 1.32 nM, 2.46 nM, 4.93
nM, 9.86 nM, 19.7 nM, 39.4 nM) and with an Hfq concentration of 6.08
nM/reaction and incubated at room temperature for 10 minutes. EMSAs were
performed on a 6% native polyacrylamide gel. B. 32P labelled RNA-IN 3’ (BM1)
[3.45 nM/reaction] was mixed with varying DsrA or polyA16 concentrations (3 nM,
6 nM, 12 nM, 15 nM) and with an Hfq concentration of 1.05 μM/reaction and
EMSAs were performed on a 6% gel. C. 32P labelled RNA-IN 3’ (BM2) [2.15
nM/reaction] was mixed with varying DsrA or A16 concentrations (1.3 nM, 2.5 nM,
5 nM, 10 nM, 20 nM) and EMSAs were performed.
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3.5 Does the BM1 mutation affect IS10 transposition frequency?
Since the 3' mutations reduce Hfq binding and Hfq binds the 3' end of
RNA-IN tightly, the in-vivo effects of the 3' mutations in a mating out assay were
tested. A new marked IS10 construct had to be made to ensure a unique 3'
region of IS10 was present for site directed mutagenesis. The construct that was
available in the lab (pDH502/pDH602) had a large portion of the 3' region of IS10
(including the SELEX site) repeated following the kanamycin gene (Figure 3.8A).
This repeated region resulted in amplification issues when trying to do site
directed mutagenesis to the SELEX site. The new construct included the IS10
sequence up to the stop codon, followed by a kanamycin gene transcribed off the
opposite DNA strand followed by the remainder of the inside end of IS10 to allow
for transposition (Figure 3.8A). The IS10 portion was mutated to make the BM1
mutation which was chosen due to its similar Hfq binding profile to the wild type
transcript (likely binding the proximal site of Hfq, unlike the BM2 mutant which
showed a different binding preference).
A mating out assay was performed with NK5830 cells transformed with
either an IS10-Kan element containing the native IS10 sequence or containing
the BM1 mutation. There was no difference in transposition frequencies between
either of the constructs (Figure 3.8B). These results suggest that the 3' SELEX
site of IS10 transposase RNA is not a region of regulation for RNA-IN 3' in the
environmental conditions of the mating out assay.
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Figure 3.8 The BM1 mutation does not affect transposition frequencies of a
high copy IS10 element as measured by a mating out assay. A. A
comparison of the old IS10-kan construct (pDH502) and the new one made for
this study (pDH725). The new construct is more modular and has less repeated
sequence. This makes gene manipulation more efficient. B. NK5830 F’ cells
were transformed with either a wildtype IS10-kan construct or an IS10-kan with a
mutated SELEX site construct and grown overnight on LB medium with
kanamycin selection [25 μg/mL]. Cells were subcultured in LB to an OD600 of ~
0.6 and the mating out procedure was followed. Total exconjugates and total
hops were calculated and transposition frequencies were calculated by dividing
the total hops by the total exconjugates. This data is compiled from 2
independent experiments both with n=4.
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As an additional method to determine which region of the transcript Hfq
may be acting upon, a series of IS10 truncations and mutations were explored in
context of IS10 transposase expression using IS10-LacZ translation fusions. The
IS10-LacZ translational fusions are comprised of varying lengths of the IS10 gene
sequence, fused to DNA sequence starting at the 9th codon of LacZ. The two 3'
mutants BM1 and BM2 were also tested in this context. The IS10-LacZ
translational fusions include the RNA-IN promoter as well as the entire RNA-OUT
promoter and sequence (see Figure 3.9). These data show a general trend of
overall transposase expression increases as the IS10 transcript gets longer (see
Figure 3.9). This trend is true for all translational fusions in both the Hfq- , Hfq+
cells. Structural predictions of the RNA using mFold suggest the increase in
activity between the different transcripts is not due to occlusion of the Shine
Dalgarno sequence nor a difference in the position of the translational start (Data
not shown). The longest IS10 translational fusion contains the predicted Hfq
binding site AAYAAYAA found in the IS Finder search, and there is about a 3 fold
increase in activity in Hfq- cells relative to wild type cells. Both BM1 and BM2
mutants resulted in about a 3 fold decrease in overall expression in both Hfq- and
Hfq+ strains (Figure 3.9). The RNA structure of the promoter region and
translational start region in the two mutants are no different than in the wild type
transcript according to the most stable structures using mFOLD structural
predictions, thus is likely not the reason for the reduced activity. Overall, it
appears that mutating the 3' end of IS10 in the context of a transposase
expression assay and a mating out assay does not affect transposase activity.
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Figure 3.9 β-Galactosidase activity for IS10-LacZ translational fusions of varying lengths. Translational
fusions were transformed into NK5830 F' (Hfq+) or its isogenic derivative DBH16 (Hfq-) and transposase
expression assays were performed. These data are a compilation of at 2 independent experiments with each
geometric shape representing one colony in a β-galactosidase assay. The SELEX site refers to the identified Hfq
binding sequence AAYAAYAA from searching the ISFINDER database. Increasing amounts of IS10 sequence
were fused to the 9th codon of a LacZ gene, as well as a mutated version of IS10 that contained 2 base changes in
the 3’ region of the transcript.
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3.6 Is the expression of RNA-IN regulated by an sRNA?
Manipulation of the 3' SELEX site of RNA-IN has a minimal effect on
transposase expression and activity regardless of the observation that Hfq binds
RNA-IN 3’ in vitro. The problem being looked at is that IS10 transposition is
down regulated by Hfq up to 86 fold on a multi-copy plasmid but only up to 7 fold
when on a single chromosomal copy 18. RNA-OUT pairing with RNA-IN is also
considered negligible at a single copy situation with hfq disruptions resulting in a
2 fold decrease in transposition 11. This led to the question: What else could Hfq
be working in conjunction with to repress IS10 expression? Accordingly, I tested
an alternative mechanism for how Hfq might be regulating IS10 transposase,
independent of the anti-sense system. One of the major roles for Hfq in the cell
is to bind RNA species and promote their pairing with mRNAs. I therefore
decided to search for E. coli sRNAs that regulate RNA-IN expression. To
address this possibility, a sRNA database sRNAMAP 69 was downloaded and the
sequences searched against RNA-IN using INTARNA 85
(http://rna.informatik.unifreiburg.de:8080/lntaRNA.jsp). INTARNA is an online
bioinformatics tool that allows one to predict the interactions between RNA
molecules. INTARNA analyzes the hybridization energy between the two
prospective pairing RNA species as well as unfolding energies required for the
regions of interaction of each molecule to become accessible. This program is
useful to find candidate RNAs that may interact with RNA of interest. An
interaction stability of -8 Kcal/mol cut off was used to reduce the number of
matches, and non-E. coli sRNAs were removed from the list. The top 20 most
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stable sRNA-mRNA predicted interactions are reported here (See Table 3.3). Of
these matches an sRNA from the most stable (GlmZ), mid-stable (SroG) and
least stable range (RdlC) were chosen to test experimentally for pairing with 5'
region of IS10. The predicted regions of interaction of GlmZ, SroG and RdlC are
shown in Figure 3.10.

Table 3.3 Compiled sRNAs predicted to interact with IS10 according to
INTARNA. Start and stop refer to the base region on the sRNA where pairing
may occur between the sRNA and IS10. Predictions are based on a minimum
seed region of 7 bases for pairing.
sRNA
sroG
rseX
omrB
C0343
sibD
glmZ
oxyS
sgrS
ssrA
tmRNA
crsB
C0719
tpke70
ryfB
C0299
rdlD
dsrB
C0465
omrB
ssrS
*rdlC

Kcal/mol sRNA
Start
-20.232
102
-18.252
11
-15.919
6
-15.661
4
-14.587
1
-14.308
132
-14.230
48
-14.124
168
-13.967
275
-13.708
153
-13.414
133
-12.984
62
-12.528
118
-12.510
123
-12.039
1
-11.877
1
-11.748
55
-11.469
12
-11.428
6
-11.420
25
-8.737
1

sRNA
Stop
130
66
46
60
24
157
82
178
326
164
181
98
160
140
51
10
73
31
46
61
8

69

IS10
Start
53
709
751
541
739
20
107
364
67
601
452
889
570
58
252
664
769
608
751
750
15

IS10
End
85
767
790
621
761
43
145
374
123
612
505
922
620
79
292
673
786
633
790
785
22

IS10
SroG

IS10
GlmZ

IS10
RdlC
Figure 3.10 Predicted regions of pairing between sRNAs and RNA-IN
according to INTARNA. Predictions are based on pairing at 37°C with a
minimum seed region of 7.
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The strategy I took to test potential sRNA-IS10 transposase mRNA
interactions, was to make an in vitro transcribed transcript of both the sRNA
candidate and IS10 transposase mRNA. These transcripts were then incubated
together at 37°C (the same temperature employed in the INTARNA program),
and ran on a polyacrylamide gel to see if base pairing occurred. A positive result
in this ‘pairing’ assay would provide impetus for genetic studies. An in vitro
transcription template was made for these sRNAs by PCR amplifying a genomic
preparation of NK5830F' with the primers specific for the corresponding RNA.
The primer pairs BM31A/BM32A, BM33A/BM34A and BM35A/BM36A were used
to amplify GlmZ, RdlC and SroG respectively. The forward primer included the
T7 RNA polymerase promoter (see Figure 3.4 for the general strategy). RNA
transcripts were made by T7 RNA Polymerase (NEB) using the T7 RNA
polymerase promoter containing template of each sRNA. The sRNAs were heat
treated at 90°C for 2 minutes, placed on ice for 5 minutes then the pipetted on the
side of a microfuge tube along with the first 160 nucleotides of
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P labeled RNA-

IN (IN-160) and centrifuged into Hfq buffer to ensure all binding reactions were
started at the same time. The reactions were incubated for 15 minutes at 37°C
and loaded on to a 5.5% native polyacrylamide gel at 21V/cm to test for base
pairing of the sRNA and RNA-IN (first 160 bp) transposase RNA. Pairing was not
detected between IS10 and SroG, GlmZ, or RdlC at any of the concentrations of
sRNA:IN-160 tested (where the sRNA was in as much as 100 fold excess over
RNA-IN) (Figure 3.11). In contrast, when RNA-IN was in excess to GlmZ, some
pairing was detected (Figure 3.11). It is important to note that experiments
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shown here are experiments done in the absence of Hfq. I was able to show that
Hfq binds GlmZ (Figure 3.12), but I did not see stimulation in pairing efficiency
when Hfq was titrated into a GlmZ-RNA-IN Pairing reaction (Data not shown).
The in silico predictions I used to devise a list of potential sRNAs that could base
pair with RNA-IN were based on conditions with the sRNA and mRNA at 37°C,
and did not include Hfq. If GlmZ is involved in IS10 regulation, we expect it to be
in an Hfq dependent manner which would explain the increase in transposition in
the absence of RNA-OUT and Hfq. To address this we tested if Hfq binds GlmZ
transcript.
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P labelled GlmZ was incubated for 15 minutes at 37°C with

increasing concentrations of Hfq. GlmZ binds Hfq and depending on the Hfq
concentration can form up to 3 complexes (Figure 3.12).
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Figure 3.11 Pairing of sRNAs to IS10 (bp1-160) only occurs when IS10 is in excess. sRNAs were incubated at
37°C in Hfq buffer and 32P labelled IS10 at the given ratios for 15 minutes. An equal volume of 2x load mix was
added to each reaction and samples were run on a 6% native polyacrylamide gel. Bottom Right: 32P labelled
GlmZ was incubated at 37°C in Hfq buffer and IS10 RNA at constant ratios for 15 minutes. An equal volume of 2x
load mix was added to each reaction and samples were run on a 6% native polyacrylamide gel.
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Figure 3.12 Hfq binds GlmZ to form 3 protein-RNA complexes. 32P labelled
GlmZ (GlmZ*) was incubated at 37°C in Hfq buffer with varying Hfq
concentrations for 15 minutes. An equal volume of 2x load mix was added to
each reaction and samples were run on a 6% native polyacrylamide gel.

3.7 Does limiting the availability of Hfq proteins in E.coli impact on IS10
transposition frequency?
In this section of the thesis I asked if reducing Hfq levels in the cell
increases IS10 transposition frequency. A proposed IS10 Hfq regulation model
from Ross et a/. suggested that cellular stress may result in the titration of Hfq
through over expression of sRNAs 18. In support of this model, data suggest that
the overexpression of an Hfq binding sRNA or mRNA can decrease sRNA
directed regulation of a target gene 54,53. The sRNAs DsrA, RhyB and MicC were
chosen to titrate Hfq as they were effective Hfq titrators in the previously
mentioned studies. We also explored the effect of the sRNAs GlmZ and SroG on
IS10 transposition frequencies. GlmZ was chosen, due to the in vitro data
suggesting IS10 can pair with it (Figure 3.11), and SroG due to its predicted
binding to IS10 from lntaRNA (Figure 3.10), as well as the availability of a SroG
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disruption strain in the laboratory. To test if reduced Hfq levels result in differing
transposition frequencies, 3 sRNAs, MicC, RhyB and DsrA, were cloned into
pACYC184 under the control of the pLlac01 promoter. Additionally, an IPTG
inducible pLlac01 GlmZ construct was generously given to us by the Gottesman
lab (NIH, Bethesda, MD). The inducible sRNA containing plasmid were cotransformed into NK5830 with a plasmid containing a kanamycin marked IS10
element and plated overnight on LB containing 25 μg/mL of kanamycin and 10
μg/mL of tetracycline at 37°C either in the presence of absence of IPTG. MicC,
RhyB and DsrA were induced with 1 mM IPTG, and GlmZ was induced with 100
μM IPTG. Resulting transformants were used to inoculate overnight cultures at
37°C in LB broth with identical additives as the plates the colonies were picked
from. Overnight cultures were subcultured in 1 ml of LB broth and a standard
mating out was performed (see Materials and Methods). One mL of the overnight
culture was used for total RNA isolation. Total RNA was isolated using acidphenol extraction, quantified and equal amounts of total RNA underwent reverse
transcription using primers specific to the sRNA. A NK5830 F' containing a sroG
gene disruption was also tested for a change in transposition frequency.
Induction of MicC resulted in a 1.7 fold increase in transposition compared to
non-induced. GlmZ, RhyB and DsrA induction had no significant effect on
transposition compared to their non-induced counter parts (Figure 3.14). Semiquantitative RT PCR shows approximately a 110 fold increase in MicC RNA in
the induced cells versus the uninduced cells and an approximately 20 fold
increase in GlmZ RNA in the included cells verses the uninduced cells (Figure
3.13). Overall, MicC overexpression caused a small increase in IS10
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transposition and I suggest this may be due to limiting the availability of Hfq in the
cell. In contrast, overexpression of a 2nd sRNA, GlmZ, did not influence IS10
transposition frequencies.

Figure 3.13 IPTG induced MicC expression (Top) and IPTG induced GlmZ
expression (Bottom). Cells NK5830 F’ cells transformed with a plasmid
containing plLacO1 MicC or pLlacO1 GlmZ and were grown to exponential phase
in the presence of 1 mM IPTG for MicC or 100 μM for GlmZ. Total RNA was
isolated and RT PCR was performed using reverse primers specific to MicC, 16S
rRNA and GlmZ.
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Figure 3.14 sRNA overexpression mating out assay (top and bottom-right).
NK5830 F’ cells were co-transformed with an inducible sRNA plasmid and a
marked IS10 element IS10 Kan (pDH502). Cells were grown overnight in
kanamycin and tetracycline (25 μg/mL and 10 μg/mL respectively) LB in either
the presence or absence of IPTG (1 mM for top graph, 100 μM for bottom right)
and then subcultured in LB in the presence or absence of IPTG (1 mM for top
graph, 100 μM for bottom right). The mating out assay was then performed.
SroG disruption strain mating out assay (Bottom-Left): NK5830 cells as well
as NK5830F’ with SroG replaced with a kanamycin gene were transformed with
pDH502. Cells were grown overnight in LB containing Ampicillin [50 μg/mL]. The
mating out assay was then performed.
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Overexpression of sRNAs can titrate out available cellular Hfq however;
the physical amount of Hfq is unchanged. To test if reducing Hfq expression
levels (a percentage of the amount of Hfq in the cell) impacts on IS10
transposition frequency I utilized a dksA disruption strain. Loss of DksA has been
shown to reduce Hfq levels by 50% in Shigella flexinari 55 and E. coli 54. To
introduce a dksA disruption into a strain suitable for the mating out assay, a P1
phage lysate was produced by infecting MG1655 Δdks::tet (a gift from M. Cashel
via S. Gottesman) with P1 phages and transducing NK5830 F' with the resulting
lysate. NK5830F' transductants were verified by PCR to contain the tetracycline
gene insertion in the dksA gene (DksA-).
The dksA::tet insertion strain of our mating out strain was transformed with
a ‘marked’ IS10 element (pDH502), grown overnight on LB plates containing
kanamycin and then overnight cultures were set up with individual colonies in LB
broth containing kanamycin. The overnight cultures were subcultured in LB broth
or LB broth containing tetracycline (to ensure the disruption was present). The
standard mating out protocol described in Materials and Methods was followed.
There was a 3-fold increase in IS10 transposition seen between NK5830F' and
DksA- NK5830F’ cells during our standard mating out conditions (37°C, grown to
exponential phase on LB broth) (Table 3.4). This result indicates that downregulating Hfq expression results in a small increase in IS10Kan transposition.
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Table 3.4 Ratios of transposition frequencies of NK5830F’ and its isogenic
mutants. IS10 transposition frequencies in NK5830 F’ wildtype and mutant cells
were determined from a mating out assay at 37°C (Normal conditions) based on
two independent experiments with n=4, except the H-NS mutant which had only 1
experiment with n=4.
Mutant/WT’

Ratio

hfq-/WT
dksA-/WT
rpoS-/WT
hns-/WT

33.14
3.03
2.12
1.03

Standard
Deviation
0.84
1.41
0.60
0.57

The transition of E. coli from exponential growth phase to stationary phase
changes the expression profile and levels of many cellular proteins. For example
Azam et a/ suggest that Hfq, H-NS and IHF (all proteins shown to be involved in
Tn10 transposition) levels all decreased after prolonged stationary phase
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.

Additionally the sRNA expression profile of a cell will change under different
growth conditions. RpoS encodes a sigma factor that plays an important role in
orchestrating changes in gene expression that facilitate a cell’s transition into
stationary phase. In this section, I asked if stationary phase stress impacts IS10
transposition frequency. A modified mating out protocol was devised in order to
determine the effect of stationary phase stress on IS10 transposition frequencies.
Our mating out strain, NK5830 F’, was transformed with pDH502 and grown
overnight on LB kanamycin plates at 37°C then individual colonies were used to
inoculate LB kanamycin broth [25 μg/ml] at 37°C. The inoculum was then left for
5 days without aeration on a bench top for growth, and then processed in a
mating out assay. These stationary phase growth conditions resulted in a 9.8 fold
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increase in IS10 transposition compared to our ‘standard’ mating out conditions
where cells are grown to exponential phase prior to the mating procedure (Table
3.5). This result suggests that growth conditions can alter IS10 transposition
frequencies.
To follow up on this observation that growth conditions can alter IS10
transposition frequencies, I asked the question: does this 9.8 fold increase
transposition events still occur in different genetic backgrounds? The goal of this
study was to determine the genetic dependencies on IS10 transposition
frequencies under starvation conditions. Three different genetic backgrounds
(rpoS-, dksA- and hfq-) of our mating out strain (NK5830) were tested for an
increase in IS10 transposition frequencies under ‘starvation’ conditions. When
analyzing the growth curves of these mutants, it became apparent that only the
rpoS- mutant provided a good comparison to the wildtype mating out strain as
dksA- and hfq- cells did not grow well under these conditions (see Figure 3.15).
Interestingly, there was no difference in transposition frequencies in the rpos
mutant when comparing to room temperature growth to 37° C, but there is an
increase in transposition in the wild type background. A possible explanation for
this could be the Hfq levels present in the two backgrounds, whereas higher Hfq
levels may reduce transposition frequencies in the rpoS- mutant. At 50 hours,
both rpoS- and NK5830 cells appear to be towards the end of exponential phase,
and at 110 hours, they both appear to be approaching death phase. One ml
aliquots of cells were obtained from RpoS or NK5830F' backgrounds and used to
quantify Hfq levels by a semi-quantitative Western Blot (Figure 3.16). There was
no significant difference in levels in Hfq levels at either time point. Therefore, the
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inability of rpoS- cells to support an increase in IS10 transposition upon
‘stationary phase’ stress does not appear to be linked to Hfq levels. Nevertheless,
this experiment has provided the 1st evidence that IS10 transposition is induced
by stationary phase stress and that this induction is dependent on the
transcription factor RpoS.
Table 3.5: Transposition frequency ratios in different growth conditions. Ratio of
transposition frequencies determined from a mating out assay at room temperature with
no aeration divided (Starved) by the transposition frequency determined at 37°C with
aeration (Normal) based on two independent experiments with n=4.

Starved/Normal

Ratio

5830/5830
dksA-/dksArpoS-/rpoShfq-/hfq-

9.81
2.65
1.02
0.15

Standard
Deviation
1.64
1.59
0.57
1.23

81

N=
'Starved’
14
9
8
10
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8
8
8
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Figure 3.15 Growth curves of NK5830 F’ and its isogenic mutants with disruptions in rpoS, dksA, and
hfq transformed with pDH502. Cultures were inoculated with a 12 hour offset in order to obtain a time point
every two hours (3 independent colonies at varying times). Cells were taken out in 1 mL aliquots at each time
point, spun down, suspended in 0.85% NaCl and diluted for plating. LB plates containing kanamycin [25
μg/mL] were incubated overnight at 37◦C and colonies were counted. The RpoS growth curve contains a large
increase in cells per mL between 22 and 26 hours. This is likely due to having the 12 hour offset and missing
the time point at 24 hours. One can see at time 0, there is one culture that started at 1 x 10 4 CFU/mL.This
culture contains 100 times more starting cells than the other 3 cultures being analyzed, so after 26 hours of
growth it will contain more cells than the other culture being measured.
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Figure 3.16 Western blots of NK5830F’ and rpoS- cell lysates. Cells were grown to either 50 hours or 110 hours at
room temperature without aeration. Cell volumes were normalized to 1 mL at an OD 600 =0.6, and that volume was
spun down and resuspended in 20μL of SDS load buffer (2% SDS, 10% glycerol, .06M Tris HCl pH6.8, .025%
Bromophenol Blue), boiled for 300 seconds then loaded on a 14% SDS-PAGE gel (10μL load) and ran at 17V/cm until
the Bromophenol Blue dye front reached the bottom of the gel. Gel was transferred on PVDF membrane at 0.6mA/cm 2
of PVDF membrane. PVDF membrane was blocked overnight in 5% fatfree milk (Nelson) dissolved in TBST buffer.
Western blotting was done with a 1/100,000 dilution of α-hfq antibody (rabbit polyclonal) and a 1/4000 dilution of a
mouse α-rabbit IgG (Promega). P-lane represents 100 ng of purified Hfq. H-lane contains cell lysate from hfq- cells
(DBH16). WT-lane contains cell lysate from wildtype cells (NK5830). R-lane contains cell lysate from rpos- cells (DBH
48). P-lane contains purified Hfq protein only.
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Chapter 4 - Discussion
4.1 Using bioinformatics to identify IS Elements that are under Hfq
regulation.
In this work we successfully identified another Hfq regulated element,
IS1413, by searching for Hfq binding sites of in IS Element transposase mRNA
sequences, instead of physically working with the element first. Further
characterization of other elements found in Tables 3.1 and 3.2 may expand the
list of Hfq regulated IS Elements from the current 3 (IS10 18, IS50 (Crystal
McClellan thesis), and now IS1413 (this work)).
This bioinformatics approach to finding IS Elements that are candidates for
Hfq regulation demonstrated several advantages over individually testing each IS
Element for a change in transposition frequencies in the presence or absence of
Hfq. First of all, there is a large data base of IS Element sequences available in
one location in the IS finder database. In its original form, the IS finder data base
makes a meta-analysis of all entries difficult; however this was overcome using a
webcrawler and a parsing macro to put all of the Element information in one easy
to search document. Once this document of all the IS-Elements was compiled, all
of the IS Element information are found in a sortable and searchable
spreadsheet. Second of all, the Hfq binding site has been rigorously defined in
sequence and structure composition. Hfq binding sites on mRNA species have
been defined in terms of sequence such as the SELEX binding site 44, the polyA
binding site 41, and the ARNx binding sites 41 . Regions of RNA that bind Hfq are
often followed by a hairpin (reviewed in

38

). Finally, the high degree of
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conservation between Hfq proteins in different bacteria, lead me to the
expectation that Hfq binding sites will also be highly conserved in different
bacteria. As mentioned previously, Pseudomonas Hfq relieves RpoS gene
inactivation in E.coli containing Hfq disruptions74 and Burkholderia cephacia
IST408-SS7 Hfq relieves the slow growth phenotype that E.coli MC4100 ΔHfq
exhibits 87. Overall, this method of identifying IS Elements that may be under Hfq
control, remains a valuable tool in the study of how prevalent Hfq regulation is
throughout the different families of IS Elements.
There still remains some issues to address regarding using the ISFINDER
searching strategy for Hfq regulated IS Elements. The first concern of this
approach is it does not take into account the secondary structure of the IS
Elements’ transposase mRNA. Hfq binding is dependent on both sequence and
structure of the RNA species (reviewed in

38

). I would predict that by adding the

secondary structure parameter into this approach would result in fewer
candidates for Hfq regulation. Future modifications of this approach to overcome
this concern could include, a scoring system that first scores candidate IS
Elements for containing the Hfq binding sequence, and then analyzing that region
for secondary structures. Conversely, although we may have more candidates by
not including the secondary structure parameter in our search, we are biasing the
results for a high percentage of type II statistical errors, due to the stringency in
the Hfq binding site searched. Not all Hfq binding sites will contain the perfect
consensus sequence AAYAAYAA found by Lorenz et al. 44, We are thus
increasing the possibility of false negatives in this search. Finally, the capacity of
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Hfq to bind an RNA site tightly does not always translate into the interaction being
biologically relevant. This phenomenon was observed in the Hfq binding site on
the 3’ end of IS10’s transposase mRNA, which upon mutation did not result in
any change in Hfq sensitivity. Despite these potential caveats of this
bioinformatics approach to identifying Hfq regulation of IS Elements, I was
successful in identifying IS1413, which did exhibit a change in transposition
frequencies in the presence of Hfq. This approach does remain a good starting
point to identify Hfq sensitive IS Elements to be followed up on using traditional
genetic and in vitro studies.
4.2 Hfq and IS1413 transposition:
These studies show that the frequency of IS1413 transposition and IS1413
transposase expression both increase in the absence of Hfq. Following up on this
observation, I tried to correlate this ‘Hfq effect’ with a validated Hfq binding site in
the 5’ UTR of the IS1413 transposase mRNA. I did this by looking at mutations in
the putative 5’ UTR of the IS1413 transposase mRNA. These mutations did not
result in an increase of transposase expression in the presence of Hfq (unlike the
hfq disruption). There are several possibilities why mutating the putative Hfq
binding site did not result in the de-repression of IS1413 transposase expression
in the presence of Hfq. The most obvious possibility is our identified binding site
may not be a bona fide Hfq binding site in vivo. Our bioinformatics data and in
vitro data support that Hfq does bind to this region, however in vivo several other
factors would be involved in a successful binding interaction such as the
accessibility of the binding site, or the availability of cellular Hfq. An interesting
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result of the IS1413 transposase mutations we looked at was that it caused an
overall increase in IS1413 transposase expression in both the presence and
absence of Hfq (see Figure 3.1). The expectation of this study was that the
mutants would have lower transposase expression in the presence of Hfq relative
to the wild type translational fusions. These mutations we introduced may have
inadvertently improved either the translation initiation or the transcript stability of
IS1413. This overall increase in IS1413 transposase expression may overshadow
any positive effects linked to the loss of Hfq binding to the transposase mRNA,
and thus we would be unable to see any subsequent repression. More mutations
will need to be made and analyzed for IS1413 to see if we are able to alleviate
Hfq repression. Our identified putative Hfq binding site in IS1413 was based on
the stringent sequence AAYAAYAA, which did not allow for any substitutions in
any position. The possibility remains that there may be other Hfq binding sites,
that are not a perfect match, are downstream of the 5’UTR that Hfq is binding to
down regulate IS1413 transposase expression. Finally, it is possible the Hfq
effect on IS1413 transposition frequencies is indirect, and is actually due to the
different genetic expression profiles between the wildtype NK5830 F’ cells, and
its isogenic hfq disruption strain DBH16.
In this work on IS1413 we were able to show that IS1413 is active in E.coli
and we were able to measure the expression of the IS1413 transposase gene in
E.coli using a translational fusion. The Hfq status of E.coli influenced both IS1413
transposition frequencies and transposase expression; both of these increased in
an hfq- E.coli strain. We have has shown that IS1413 is an active element that
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can transpose in E.coli with a transposition frequency of 3.7 x 10-5 transposition
events per mL of mating mix in the presence of Hfq and 5.0 x 10 -4 transposition
events per mL of mating mix in the absence of Hfq. These results suggest that
Hfq has a repressing role on IS1413 expression. This is more evidence for the
notion that Hfq is a general regulator of IS Elements. Subsequently, with Hfq
being linked to cellular stress responses 88, these results provide a possible
pathway for linking IS1413 transposition to cellular stress pathways. In other
words, under certain conditions the host may be more permissive to transposition
events which may result in the transposon induced gene expression changes,
such as the expression of the tft operon to allow for the utilization of phenol
compounds as a carbon source.
The observation that IS1413 is active in E. coli is an example of how IS
Elements can be promiscuous carriers of genes from one bacterial population to
another. Since IS1413 is also active in Burkholderia 56 , this opens up the
possibility that Burkholderia and E. coli could potentially exchange genes through
IS1413 mediated transposition. This gene exchange would entail IS1413
carrying additional genes with it during a transposition event onto a conjugative
plasmid and transferring it to another species. Species of the genus Burkholderia
are commonly found in water in soil and sometimes as plant or human pathogens
89

. E. coli is primarily found in the lower intestine of warm blooded animals as

well as in water, sediment and soil 90. It is very possible these two organisms
could be found in a common habitat such as soil, and share genes through
conjugation and transposition events. The identification of IS1413 being active in
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E. coli opens up the possibility that it could be an agent of pathogenicity transfer
between the two organisms. For example, if IS1413 flanks a pathogenicity gene
in E.coli or an antibiotic resistance factor, it may move onto a transmissible
plasmid (such as the F-factor). If this IS1413 harbouring pathogenic E.coli is
passed into soil by an infected animal and Burkholderia phenoltripix is also
present, through conjugation Burkholderia phenoltripix may acquire the ability to
infect an animal that consumes that soil (See Figure 1.1 for mechanisms that
could account for this).
Our results show Hfq influences IS1413 expression and transposition
frequencies; this provides us with further understanding of how IS1413
transposition is regulated. IS1413 is not a well-studied transposon. Prior to this
study, IS1413 was identified to be active in Burkholderia phenoltripix 56.
Subsequently, it was demonstrated that IS1413 can up regulate the tft operon in
Burkholderia phenoltripix. The first gene in the tft operon is involved in the
breakdown of 2,4,5 tricholorophenol (i.e. Agent Orange)
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. By further

understanding the regulation of IS1413 and its activation of the tft operon, one
could potentially utilize Burkholderia phenoltripix for bioremediation of areas
polluted with 2, 4, 5 tricholorophenol compounds such as Agent Orange.
Ultimately, one would hope on identifying conditions that would facilitate the up
regulation of the tft operon and thus facilitate the degradation of these toxic
compounds.
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4.3 Hfq regulation of IS10
An objective of my thesis was to fully identify how Hfq represses IS10
transposase. There were two main reasons for why I looked at Hfq regulation of
IS10 transposase. First of all, my bioinformatics screen predicted that there is an
Hfq binding site in the 3’ end of the transposase transcript. Secondly, previous
studies by Ross et al. suggest there is Hfq regulation independent of the IS10
transposase transcript. I looked at the possibility that Hfq regulates IS10
transposase, at least in part, by binding the 3’ end of the transposase transcript
where my bioinformatics analysis predicted the existence of an Hfq binding site.
An example of Hfq binding the 3’ end of a transcript and the effects it can
have are seen in the interactions of cspA mRNA and Hfq. Hfq protects cspA
mRNA from RNase E mediated degradation. It also increases the length of a
polyA tail due to polyadenylate polymerase
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. With a putative 3’ binding site in

the IS10 transposase, I decided to characterize the 3’ end of the IS10
transposase transcript to look for evidence of polyadenylation. The presence of
polyadenylation on the transposase transcript would have been consistent with
the 3’ SELEX site and Hfq playing a role in processing of the transcript. Results
the 3’ RLM-RACE did not show any evidence of polyadenylation of either IS10L
or IS10R. The identified end may be a processed transcript that occurs following
transcription. Nonetheless, I did successfully define a 3’ end for both IS10R and
IS10L. Previous studies have never determined this prior to this work. Future
directions to confirm the true 3’ end of IS10 could include an RNA protection
assay to verify the predicted 3’ end of IS10 predicted by the 3’ RLM-RACE.
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Understanding precisely how the IS10 transcript terminates may provide some
insight into the effect Hfq has on reducing its half-life.
To characterize the putative Hfq binding site in the 3’ end of IS10 transposase
transcript, I utilized RNA-Hfq binding studies and transposase expression studies.
Through binding studies, I found that Hfq binds to the 3’ site when a portion of the
transposase transcript was studied. When trying to initially determine the regions
that are important for Hfq regulation of IS10, different lengths of IS10 were used
to make translational fusions with LacZ. A general trend observed in this set up
was the longer the transcript, the more active the fusion was. Generally, Hfq
repressed the overall activity of the transcript in all of the translational fusions
about 3 fold. However, the fusions containing very small amounts of IS10 (180
bp or 290 bp) have transposase expression barely above the ‘cells only’ control.
One possibility as to why the longer fusions were more active is due to the
shorter transcripts not being able to fold properly. Improperly folded transcripts
would have a greater chance of being degraded by single stranded specific
RNases. When the 3’ SELEX site in the IS10 transposase LacZ translational
fusions was disrupted through site directed mutagenesis, Hfq repression was not
relieved. There are a few possible reasons for why we were unable to de-repress
Hfq regulation of IS10 transposase expression. First, Hfq may be unable to bind
the 3’ SELEX site in the IS10 transposase transcript in vivo. Second, Hfq may be
able to bind the 3’ SELEX site in the IS10 transposase transcript in vivo, however
under the conditions we tested it may be missing another factor required to elicit
a biological response. This missing biological factor could be an sRNA that is
only expressed under certain stress conditions.
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Overall, the bioinformatics approach I took to identify Hfq regulation sites in
transposase transcripts was successful in the case of IS1413, but not for IS10.
This project successfully identified a new Hfq-regulated transposase, IS1413,
however this may be fortuitous. Further characterization of the sensitivity of
transposase expression to Hfq of my bioinformatics identified elements and a
random list of IS Elements would help put my approach to the ultimate test. If my
bioinformatics approach results in a higher proportion of Hfq sensitive
transposases compared to the random list, this would suggest that the initial in
silico screen provides a list of candidates that one should follow up on.

4.4 RNA-IN has an Hfq binding site in the 3’ end and it may be relevant
under certain physiological conditions.
The data from the 3’ RLM-RACE data suggests that there may not be any
post transcriptional modifications of IS10 (Figure 3.3). In vitro binding studies
show that Hfq is able to tightly bind the 3’ end of RNA-IN and mutating the
putative Hfq binding sequence reduces the apparent binding affinity Hfq. So if
Hfq binds the transcript, why do we see no effect in the mating out assay when
we mutate the 3’ end? One possibility is that under the conditions used for the in
vitro data favoured the binding of Hfq whereas as the mating out conditions did
not permit Hfq binding. Hfq binds not only in a sequence specific manner but
also in a secondary structure dependent manner. For example, in the case of
Hfq dependent sRNAs the basic requirements for productive Hfq binding include
a hairpin flanked by U rich regions 76. One could envision conditions that may
alter secondary structures of RNA molecules such as cold shock or extreme heat.
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An example of this is in RNA thermometers where mRNA transcripts form selfinhibiting structures blocking their RBS, but when presented with specific
environmental conditions they undergo a conformational change which permits
translation (reviewed in 93). It is possible that the conditions we tested for a
phenotype in both the β-galactosidase assay and the mating out assay are not
permissive for the appropriate secondary structure to form and thus no productive
Hfq binding occurs (See Figure 4.1). Another possibility remains that the
function of the 3’ end of the RNA molecule may act as an Hfq chelator under
certain conditions, as a method of the element to modulate cellular Hfq
availability and thus increasing the amount of RNA-IN transcript available in the
cell and thus more transposition under times of stress (See Figure 4.1). Future
directions should be to identify conditions that alter the IS10 transposition
frequency of Hfq+ cells but not Hfq- cells. Such a condition may have
inadvertently been identified already with the room temperature data (discussed
further below).
4.5 Is IS10 transposition regulated by an sRNA
In this study I utilized another bioinformatics approach (INTARNA) to
define sRNAs that may regulate IS10 transposase expression. From the list of
potential sRNA-IS10 mRNA interactions, I studied 3 sRNAs: GlmZ, SroG and
RdlC. In vitro binding studies with HFQ revealed that GlmZ was the only of the 3
sRNAs that pairs with the 5’ end of IS10 transposase mRNA. However,
overexpression of GlmZ did not have an impact on IS10 transposition frequencies
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in a mating out assay. These results suggest that the weak in vitro interaction
between IS10 and GlmZ is not biologically relevant.

Figure 4.1 Model for potential conditions that may change the ability for Hfq
to bind a transcript. (Left) Growth of E. coli at our standard lab conditions
(37°C, with aeration) is not permissive to 3’ RNA-IN Hfq regulation, resulting in
Hfq being available to promote base pairing of RNA-IN and RNA-OUT, resulting
in inhibited IS10 transposase translation and subsequence degradation of the
mRNA transcript. (Right) In growth conditions that alter the folding of the RNA-IN
transcript, Hfq may be able to bind the 3’ region resulting in 2 possible
mechanisms. The first possibility is that Hfq may get titrated away from the 5’
binding site, resulting in reduced RNA-IN/RNA-OUT pairing and ultimately
increased translation. The second possibility is that Hfq may facilitate degradation
under certain growth conditions either through an expressed sRNA specific to
those conditions, or a general nuclease mediated degradation (such as PNPase).
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4.6 Does modulation of Hfq levels have an impact on IS10 transposition?
Ross et al suggest a mechanism of Hfq regulation of IS10 where stress
environments promote the overexpression of sRNAs which in turn occupy Hfq
RNA binding sites. This ‘chelating’ effect on Hfq may result in less Hfq available
in the cell to promote the pairing of RNA-OUT and RNA-IN, resulting in a
reduction of IS10 transposase expression 18. The initial inducer of sRNA
expression is often a change in environmental conditions, and the bacterial cell
can modulate gene expression through the expression of sRNAs. Therefore,
under certain stresses, Hfq binding sRNAs can be expressed which bind Hfq, derepressing the Hfq down regulation of IS10 transposase expression and
consequently increasing IS10 transposition frequencies.
The overexpression of MicC in our wildtype (Hfq+) mating out E.coli strain
resulted in an increase of in IS10 transposition of 1.7 fold compared to the
uninduced and vector only controls. MicC has already been shown in prior
studies (53,54), to alter the expression of genes that are subject to Hfq repression
or activation. Furthermore, I have identified a growth condition where forcing cells
to incubate for prolonged periods in stationary phase that results in a 10 fold
increase in IS10 transposition frequencies in wildtype cells, compared to normal
growth conditions but not in an rpoS gene disruption strain. This is the first study
done that links RpoS to a decrease in IS10 transposition frequencies when cells
are in stationary phase.
The observation that MicC overexpression results in an increase of 10 fold
in IS10 transposition frequencies suggests a possible link between cellular stress
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and IS10 transposition. For example, MicC sRNA expression is induced when
E.coli cells are exposed to cellular stresses such as low temperatures (24°C),
osmotic shock, the herbicide Paraquat, and when grown in conditions where
glycerol is the only carbohydrate source 37. If these cellular stresses induce MicC
expression, and MicC expression results in an increase in IS10 transposition, is it
possible that these cellular stresses result in increased IS10 transposition?
Follow up experiments on the effect of sRNA overexpression on IS10
transposition studies should focus on these stresses that may increase IS10
transposition frequencies. These studies will help us understand the role
transposition of transposable elements as a possible mechanism for cells to
adapt to cellular stress.
Previous studies have already been done on the role of IS10 and stress
adaptation of the cell. For example, studies have been to on the effects of UV
light induction of IS10 transposition 94. Another study was done on the osmotic
stress adaption of rpoS deletion strains of E.coli, where the authors found that
RpoS deletion strains consistently adapted to osmotic stress through IS10
transposition in front of the otsBA operon (an RpoS dependent operon)95. This
study is the first one to directly link RpoS as a regulator of IS10 transposition in
terms of transposition frequencies in stationary phase. It is also the first study to
link the sRNA MicC to IS10 transposition.
Follow up experiments to test the how Hfq levels impact IS10 transposition
rates should include using microarray data to determine how gene expression
profiles change in wild type and mutants with the rpos gene disruption in the two
growth conditions we analyzed in this work. Using these expression profiles and
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through gene deletion strains of E.coli, we could focus on specifically how the
rpoS mutant is down regulating IS10 transposition. It would be interesting to see
the effects of our stationary phase growth conditions on known regulators of IS10
transposition such as H-NS (a positive regulator of IS10 transposition) and
Integrative Host Factor (IHF) (a host factor that promotes end pairing of the IS10
transpososome.). The effect of stationary phase and IHF and H-NS have already
been studied by Azam et al. where the abundance of IHF actually increase as
well as the abundance of H-NS actually decreased by 40% at stationary phase.
Follow up experiments to how growth conditions can affect IS10 transposition
frequencies should include the characterization of the minimal amount of time of
cell growth required to observe the increase of IS10 transposition frequencies in
wildtype cells. Furthermore, an experiment testing different conditions should be
conducted so we can really understand the specific factors that contribute to the
increase in IS10 transposition, for example was it the lower temperature that
resulted in the increase of transposition frequencies or was it the stationary
phase? The most interesting follow up experiments should really characterize the
genetic landscape of the rpoS disruption strain and the wildtype strain under the
stationary phase growth conditions. It is intriguing as to why the wildtype strain
has an increase in IS10 transposition yet the rpoS deletion strain maintains the
same IS10 transposition frequency when grown into exponential phase. Further
experiments are required to elucidate just how RpoS is down regulating IS10
under stationary phase growth conditions and whether or not this is a direct effect
or due to the induction of an sRNA or the up regulation of a stationary phase
response gene.
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This work has further explored the how host factors in bacteria regulate
the expression of mobile genetic elements. In this work I have provided another
example of an Hfq repressed IS Element (IS1413) as well as a growth condition
that increases IS10 transposition elements in the presence of RpoS but not in the
absence. These findings provide a greater glimpse into factors that affect the
mobility and expression of IS Elements in bacterial populations. By understanding
what permits IS Element mobility and conditions that promote IS Element
mobility, we are one step closer to understanding how we can control the
movement of mobile genes in populations. If we eventually can control the
movement of mobile genetic elements in populations, we can use these mobile
genes for the benefit of the environment through bioremediation (such as in the
case of IS1413) or to prevent the rampant spread of antibiotic resistance genes
through bacterial populations in our health care facilities.
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Appendix 1- Obtaining a compiled list of IS Elements from the IS Finder
database.
In order to search the IS Finder database for sequences that contained
putative Hfq binding sites, the sequences had to be compiled into a series of files
that could be sorted and searched. In their native state, the sequences had to be
accessed one by one on the IS Finder database; searching the 3478 active links
in the database one by one was not a viable option. Firstly, a list of urls of each
element entry had to be compiled. This was achieved by searching for each IS
Family number one by one (IS1, IS3, IS4, IS5, IS6, IS21, IS30, IS66, IS91, IS110,
IS200, IS605, IS256, IS481, IS630, IS982, IS1380, ISAs1, ISL3, Tn3, IS1595,
IS1182, IS1634, ISH3, IS701) and copying the IS Element names into a Microsoft
Excel 2010 worksheet in column A. All IS Finder urls have a common address of
“http://www-is.biotoul.fr/index.html?is_special_name=” so by using the
concatenate function of MS Excel 2010, one can paste the following function in
column B to obtain a list of URLs to be searched:
“CONCATENATE("http://wwwis.biotoul.fr/index.html?is_special_name=",A
1)”
This list of URLs was then pasted into WEBSPHINX77. Using the concatenate
function within WEBSPHINX77, all the information about the elements within each
family was merged into one text file (.txt), which was then parsed as described
below.
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Script A1.1 contains the find and replace script I used to parse the IS
Finder Data base into a tab deliminated document. The scripting language is
Microsoft Visual Basic for Applications. Extra text was removed from the
compiled IS Finder database to conserve computer resources and the following
fields remained: Element, Host, Transposition Determined, IS_Sequence,
Comments, and References. The resulting document allowed for an Excel 2010
workbook to be made, so all elements within each IS-Family could be searched
for the putative Hfq binding sites AAYAAYAA and AYAATAA, using Microsoft
Excel’s built in find function. Due to the variability of IS Elements in GC content,
a probability (depicted as a P-Value in Tables 3.1 and 3.2) was also calculated of
how likely it was to find the number of SELEX sites I did, taking into account the
length and GC content of each element. For example, if an element is very long
and has an abundance of adenine and thymine bases, one would expect to find
more SELEX sites compared to an IS Element with a very high GC content. This
was accomplished using a cumulative binomial distribution which gives the
probability of finding exactly 1 SELEX site in IS10 for example. Outlined below
are two calculations for the IS10 Element for both SELEX sites AAYAAYAA
(Calculation A1.1) and AYAATAA (Calculation A1.2).
Calculation A1.1: The calculation of the probability of finding exactly 1
AAYAAYAA SELEX site in the IS10 Insertion Sequence transposase mRNA.
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Let p represent probability
Sequence = AAYAAYAA
Length = 1329 bp
Number of potential sequences with a stretch of 8 nucleotides = 1329-7
Number of trials = 1322
GC Content = 44%
p of G = 0.22 (or 22%)
p of C = 0.22 (or 22%)
p of A = 0.28 (or 28%)
p of T = 0.28 (or 28%)

pAAYAAYAA= 0.0001205
In this case of using the binomial distribution a success would be the SELEX site
is present.
The binomial distribution is represented by:

For IS10 we found 1 SELEX site over 1329bp so:
x=1
N = 1322

Calculation A1.2: The calculation of the probability of finding exactly 1
AYAATAA SELEX site in the IS10 Insertion Sequence transposase mRNA.

Let P represent probability
Sequence = AYAATAA
Length = 1329 bp
Number of potential sequences with a stretch of 8 nucleotides = 1329-7
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Number of trials = 1322
GC Content = 44%
P of G = 0.22 (or 22%)
P of C = 0.22 (or 22%)
P of A = 0.28 (or 28%)
P of T = 0.28 (or 28%)

pAYAATAA= 0.00024

In this case of using the binomial distribution a success would be the SELEX site
is present.
The binomial distribution is represented by:

For IS10 we found 1 SELEX site over 1329bp (1322 trials) so:
x=1
N = 1322
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Script A1.1: Visual Basic for Applications macro code used to parse IS Finder
files for export into searchable files.
Sub IS_PARSER()
'Start the script at the very top of the document
Selection.HomeKey Unit:=wdStory
' allows Wild card to recognize ^p as $
'Find within the selected text. In this case because no text is selected, the
whole document is searched.
With Selection.Find
' What string are you looking for
.Text = "^p"
' What would you like to replace it with?
.Replacement.Text = " $^p"
' Search forward in the document
.Forward = True
' Ensures the whole document is searched
.Wrap = wdFindContinue
' Wildcards are disabled
.MatchWildcards = False
' Every instance of the word is replaced
.Execute Replace:=wdReplaceAll
End With
' allows Wild card to recognize ^v as $
With Selection.Find
.Text = "^v"
.Replacement.Text = " $^v"
.Forward = True
.Wrap = wdFindContinue
.MatchWildcards = False
.Execute Replace:=wdReplaceAll
End With
'Remove the First line of Each Entry
With Selection.Find
.Text = "Result of your query $^p"
.Replacement.Text = ""
.Forward = True
.Wrap = wdFindContinue
.MatchWildcards = False
.Execute Replace:=wdReplaceAll
End With
'remove tabs to deliminate wanted fields
With Selection.Find
.Text = "^t"
.Replacement.Text = ""
.Forward = True
.Wrap = wdFindContinue
.MatchWildcards = False
.Execute Replace:=wdReplaceAll
End With
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'Remove the First line of Each Entry
With Selection.Find
.Text = "Result of your query $^p"
.Replacement.Text = ""
.Forward = True
.Wrap = wdFindContinue
.MatchWildcards = False
.Execute Replace:=wdReplaceAll
End With
'Removes all text between "Synonyms" and "Hosts" and replaces it with
"Hosts:"
With Selection.Find
.Text = "SynonymsIsoFamilyGroup*OriginHosts"
.Replacement.Text = "Hosts:"
.Forward = True
.Wrap = wdFindContinue
'Wildcard characters enabled
.MatchWildcards = True
.Execute Replace:=wdReplaceAll
End With
'Put a tab character in front of "Hosts:"
With Selection.Find
.Text = "Hosts:"
.Replacement.Text = "^tHosts:"
.Forward = True
.Wrap = wdFindContinue
'Wildcard characters Disabled again
.MatchWildcards = False
.Execute Replace:=wdReplaceAll
End With
'Enable Wildcard, removes text between Accension and Transposition
With Selection.Find
.Text = "Accession NumberLengthIRDR*Transposition:"
.Replacement.Text = "Transposition:"
.Forward = True
.Wrap = wdFindContinue
.MatchWildcards = True
.Execute Replace:=wdReplaceAll
End With
'Disable Wildcard, Tab deliminate Transposition field
With Selection.Find
.Text = "Transposition:"
.Replacement.Text = "^t Transposition"
.Forward = True
.Wrap = wdFindContinue
'Wildcard characters Disabled again
.MatchWildcards = False
.Execute Replace:=wdReplaceAll
End With
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'Delete "*" make sure wild cards are disabled, or you will lose all your text
With Selection.Find
.Text = "*"
.Replacement.Text = ""
.Forward = True
.Wrap = wdFindContinue
'Wildcard characters Disabled again
.MatchWildcards = False
.Execute Replace:=wdReplaceAll
End With
'Delete Sequence BTW ORF and IS_SEQ; Enable Wild Card,
With Selection.Find
.Text = "ORF:*IS_SEQ:"
.Replacement.Text = "IS_SEQ:"
.Forward = True
.Wrap = wdFindContinue
'Wildcard characters Enabled again
.MatchWildcards = True
.Execute Replace:=wdReplaceAll
End With
'Tab Deliminate IS_SEQ field
With Selection.Find
.Text = "IS_SEQ:"
.Replacement.Text = " ^t IS_SEQ:"
.Forward = True
.Wrap = wdFindContinue
'Wildcard characters Disabled again
.MatchWildcards = False
.Execute Replace:=wdReplaceAll
End With
'Delete the text between IS_PEP: and Comments
With Selection.Find
.Text = "IS_PEP:*Comments:"
.Replacement.Text = "Comments"
.Forward = True
.Wrap = wdFindContinue
'Wildcard characters Enabled again
.MatchWildcards = True
.Execute Replace:=wdReplaceAll
End With
'Tab deliminates Comments:
With Selection.Find
.Text = "Comments"
.Replacement.Text = "^t Comments:"
.Forward = True
.Wrap = wdFindContinue
'Wildcard characters Enabled again
.MatchWildcards = False
.Execute Replace:=wdReplaceAll
End With
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' Remove all paragraph breaks #This will take awhile
With Selection.Find
.Text = "^p"
.Replacement.Text = ""
.Forward = True
.Wrap = wdFindContinue
'Wildcard characters Disabled again
.MatchWildcards = False
.Execute Replace:=wdReplaceAll
End With
' Separates each entry as a new paragraph
With Selection.Find
.Text = "Page ^#"
.Replacement.Text = "^p Page 1"
.Forward = True
.Wrap = wdFindContinue
'Wildcard characters Disabled again
.MatchWildcards = False
.Execute Replace:=wdReplaceAll
End With
' Tab Deliminates References Section
With Selection.Find
.Text = "References:"
.Replacement.Text = "^t References:"
.Forward = True
.Wrap = wdFindContinue
'Wildcard characters Disabled again
.MatchWildcards = False
.Execute Replace:=wdReplaceAll
End With
' Delete $ place holders
With Selection.Find
.Text = "$"
.Replacement.Text = ""
.Forward = True
.Wrap = wdFindContinue
'Wildcard characters Disabled again
.MatchWildcards = False
.Execute Replace:=wdReplaceAll
End With
' Delete webpage breaks
With Selection.Find
.Text = "-"
.Replacement.Text = ""
.Forward = True
.Wrap = wdFindContinue
'Wildcard characters Disabled again
.MatchWildcards = False
.Execute Replace:=wdReplaceAll
End With
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'Replace Page # with IS_ELEMENT Tab delimited
With Selection.Find
.Text = "Page ^#^#^#"
.Replacement.Text = "^t IS_ELEMENT: "
.Forward = True
.Wrap = wdFindContinue
'Wildcard characters Disabled again
.MatchWildcards = False
.Execute Replace:=wdReplaceAll
End With
With Selection.Find
.Text = "Page ^#^#"
.Replacement.Text = "^t IS_ELEMENT: "
.Forward = True
.Wrap = wdFindContinue
'Wildcard characters Disabled again
.MatchWildcards = False
.Execute Replace:=wdReplaceAll
End With
With Selection.Find
.Text = "Page ^#"
.Replacement.Text = "^t IS_ELEMENT: "
.Forward = True
.Wrap = wdFindContinue
'Wildcard characters Disabled again
.MatchWildcards = False
.Execute Replace:=wdReplaceAll
End With
'Replace IS Finder URL with ISELEMENT name
With Selection.Find
.Text = "<[http://wwwis.biotoul.fr/is/scripts/is_spec.php?name="
.Replacement.Text = "^p["
.Forward = True
.Wrap = wdFindContinue
'Wildcard characters Disabled again
.MatchWildcards = False
.Execute Replace:=wdReplaceAll
End With
'Replace Delete double IS_Element
With Selection.Find
.Text = "^p"
.Replacement.Text = "$"
.Forward = True
.Wrap = wdFindContinue
'Wildcard characters Disabled again
.MatchWildcards = False
.Execute Replace:=wdReplaceAll
End With
With Selection.Find
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.Text = "$*$"
.Replacement.Text = "^p"
.Forward = True
.Wrap = wdFindContinue
'Wildcard characters Enabled again
.MatchWildcards = True
.Execute Replace:=wdReplaceAll
End With
'Remove Field Names for proper Export as a Table
With Selection.Find
.Text = " IS_ELEMENT: "
.Replacement.Text = ""
.Forward = True
.Wrap = wdFindContinue
.MatchWildcards = False
.Execute Replace:=wdReplaceAll
End With
With Selection.Find
.Text = "Hosts: "
.Replacement.Text = ""
.Forward = True
.Wrap = wdFindContinue
.MatchWildcards = False
.Execute Replace:=wdReplaceAll
End With
With Selection.Find
.Text = " IS_SEQ: "
.Replacement.Text = ""
.Forward = True
.Wrap = wdFindContinue
.MatchWildcards = False
.Execute Replace:=wdReplaceAll
End With
With Selection.Find
.Text = " Comments: "
.Replacement.Text = ""
.Forward = True
.Wrap = wdFindContinue
.MatchWildcards = False
.Execute Replace:=wdReplaceAll
End With
With Selection.Find
.Text = " References: "
.Replacement.Text = ""
.Forward = True
.Wrap = wdFindContinue
.MatchWildcards = False
.Execute Replace:=wdReplaceAll
End With

108

With Selection.Find
.Text = " Transposition "
.Replacement.Text = ""
.Forward = True
.Wrap = wdFindContinue
.MatchWildcards = False
.Execute Replace:=wdReplaceAll
End With
'Move to the top of the document and Title Fields for Excel export
Selection.HomeKey Unit:=wdStory
Selection.TypeText (vbTab & "IS_Element" & vbTab & "Host" & vbTab &
"Transposase Tested" & vbTab & "IS_SEQ" & vbTab & "Comments" & vbTab &
"References" & vbCrLf)

End Sub
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